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ABSTRACT: A library of positional isomers of D-glucose (O-1−O-
6) as ligands and their 11 light-active ruthenium conjugates has been
synthesized. A protecting group strategy without the necessity of
using palladium on carbon for the modiﬁcation for the 2-O and 4-O
position allows for the incorporation of sulfur donor atoms as
ligands for transition metal complexes.
■ INTRODUCTION
Carbohydrates are a class of biomolecules ubiquitously present
in nature, comprising monosaccharides, oligosaccharides, and
polysaccharides, of which monosaccharides cannot be hydro-
lyzed further into smaller units. These molecules are recognized
as important building blocks in the cell wall of bacteria,1,2 in
plants,3 in the exoskeleton of insects,4 in cell recognition
processes,5 and in the backbone of RNA and DNA6 and are
associated with many diﬀerent physiological and disease-related
processes.7,8 Among them, D-glucose is the most well-known
monosaccharide as it serves as the primary source of chemical
energy in eukaryotic cells for the production of ATP.9 Otto
Warburg found that cancer cells have an increased glycolysis rate
for the production of ATP compared to normal cells.10 As a
consequence, glucose transporters (GLUTs) 1 and 3 are
overexpressed in cancer cells.11 In recent years, there has been
a growing interest in using this eﬀect to selectively deliver
molecules of interest to cancer cells. In the ﬁeld of diagnostic
imaging, the well-known radiotracer 2-deoxy-2-[18F]-
ﬂuoroglucose (2-FDG) selectively accumulates in cancer cells
since its metabolic breakdown is hampered by the replacement
of a hydroxyl group on the 2-position of D-glucose by ﬂuoride.12
This clinically approved agent allows PET imaging of tumors
anywhere in the whole body. In the ﬁeld of medicinal chemistry,
glufosfamide has shown some success as a safer alternative for
ifosfamide, an alkylating agent used in cancer treatment. The
therapeutic eﬃciency of glufosfamide is thought to be higher due
to its increased water solubility and preferred uptake in
malignant cells versus normal cells.13 Recently, Palay et al.
have demonstrated that a series of glucose conjugates of
platinum-based medicines are taken up via GLUT1.14,15 This
result is in contrast to the observation of Schubiger, who found
that none of their radiodiagnostic glycoconjugates based on
99mTc were taken up via glucose transporters.16
For ruthenium(II) polypyridyl-based drugs, this eﬀect has not
been thoroughly investigated. Our group has been involved in a
research program aimed at targeting ruthenium-based light-
activated anticancer prodrugs to GLUT transporters by glucose
conjugation.17,18 These photoactivated chemotherapeutic pro-
drugs are typically protected from binding to biomolecules in the
dark by thioether ligands, which under visible light irradiation
are photosubstituted by water, thereby activating the pro-
drug.19−21 En route to functionalizing such complexes with
glucose, it came out that all available synthetic routes toward a
series of positional isomers of glucose were incompatible with
the presence of thioether groups, which deactivate Pd/C
catalysts used to deprotect benzyl protecting groups. For that
reason, we developed and report here on a series of new
synthetic routes toward all positional isomers of glucose that are
compatible with the presence of sulfur-based ligands.22 As traces
of palladium also often interfere with the biological activity of
pharmaceuticals,23 these new routes do not make use of
palladium catalysts. PEGylation of all positional isomers was also
realized to vary the spacer between the thioether ligands and the
glucose moiety. The coordination of the thioether−glucose
ligands to known photoactive ruthenium(II) polypyridyl
precursors aﬀord 11 ruthenium−glucose conjugates (Figure 1)
as a demonstration that such molecules can be obtained on a
synthetical useful scale. Recent publications describe the more
photophysical and/or biological properties of these type of
complexes.17,18
■ RESULTS AND DISCUSSION
Five hydroxyl groups are available for modiﬁcation in D-glucose,
of which the 1-O position is modiﬁed via chemical
glycosylation.24 Recently, Patra et al. have demonstrated that
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the spacer length exerts inﬂuence over the GLUT-mediated
uptake of platinum complexes in cells;14 however, there is
currently no established understanding of this eﬀect in cationic
ruthenium(II) polypyridyl compounds. Therefore, oligoethy-
lene glycol spacers [OCH2CH2]nwith varying lengths (n = 0−3)
were introduced in glycoconjugates [1](PF6)2−[5](PF6)2
(Figure 1). The ﬁrst complex in this series ([1](PF6)2) was
synthesized starting from precursor 12 (Scheme 1).25 This
building block and NaSMe were used in a SN2 reaction, ensuring
the installment of the thioether group, aﬀording 13. This ligand
was then reacted with [Ru(tpy)(bpy)Cl]Cl, aﬀording the
orange (λmax = 450 nm) glycoconjugate [1](PF6)2.
For complex [2](PF6)2, a three-step one-pot synthesis
starting from peracetylated glucose 14 (Scheme 2) was adapted
from Valerio et al.,26 which aﬀorded the trans-glucopyranoside
as the only diastereoisomer. Treatment of this compound with
sodium methoxide in methanol aﬀorded fully deprotected 15 in
a 55% overall yield. Subsequent reaction of this ligand with
[Ru(tpy)(bpy)Cl]Cl then gave the orange complex [2](PF6).
A diﬀerent approach was employed for the installment of the
ethylene glycol-based linkers (n = 1−3) for complexes
[3](PF6)2−[5](PF6)2 and [11]Cl2 (Figure 1). The disarmed
Schmidt donor 20 (Scheme 3) was chosen due to its
straightforward synthesis and robustness. The benzoyl protect-
ing group in this building block was favored over the more
common acetyl group, due to its lower reactivity.27 Furthermore,
this donor was chosen to reduce the possible formation of
orthoesters, a common side reaction when using acetyl-bearing
donors.28 Commercially available 2-(methylthio)ethanol was
used as an acceptor and condensed with donor 20 (Scheme 3),
aﬀording 21, which after de-O-benzoylation acquired depro-
tected 24. Compounds 25, 26, and 28 were acquired in a similar
fashion using acceptors 18, 19, and 1,3-bis(methylthio)propan-
2-ol, respectively. The synthesis of the corresponding ruthenium
complexes was found to be straightforward, by reacting excess
ligand with the ruthenium species [Ru(tpy)(bpy)Cl]Cl or
[Ru(bpy)2Cl2]. Their puriﬁcation, however, was found arduous
due to the increased water solubility of these compounds.
Figure 1. Overview of O-1 to O-6 positional D-glucose ruthenium(II) polypyridyl conjugates presented in this study.
Scheme 1a
aReaction conditions: (a) (i) NaSMe in DMF, rt, 16 h, (ii) NaOMe
in MeOH, 66% over two steps; (b) [Ru(tpy)(bpy)Cl]Cl in H2O, 80
°C, 16 h, 39%.
Scheme 2a
aReaction conditions: (a) (i) I2, Et3SiH in DCM, rt, 10 min, (ii)
thiourea in MeCN, 80 °C, 30 min, (iii) MeI, Et3N, rt, 10 min, (iv) cat.
NaOMe in MeOH, rt, overnight, 57% over four steps; (b)
[Ru(tpy)(bpy)Cl]Cl in H2O, 80 °C, 48 h, 28%.
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Common workup methods were not applicable, and the lability
of these compounds on C-18 columns prevented reverse-phase
chromatographic puriﬁcation. The most reproducible approach
was by puriﬁcation over silica using a mixture of acetone, water,
and aqueous KPF6, followed by Sephadex LH-20 size exclusion
puriﬁcation to remove excess salt and minor impurities. This
method aﬀorded the orange (λmax = 450 nm) ruthenium
polypyridyl derivatives [3](PF6)2−[5](PF6)2 and [11]Cl2 in
moderate to good yields (28−66%).
Park and co-workers have demonstrated that glucose
bioprobes with a formal charge of +1 are taken up preferentially
over neutral and negatively charged probes.29 To allow future
study of the eﬀect on the overall charge for ruthenium(II)
polypyridyl drugs on uptake and toxicity, a derivative of
[Ru(tpy)(bpy)Cl]Cl bearing a negative charge on the spectator
terpyridine ligand was also synthesized. Compound 31 (Scheme
4) was prepared starting from thione 29,30 which was oxidized
using in situ generated peracetic acid followed by hydrogenation
using 10% palladium on carbon to reverse partial overoxidation
to itsN-oxide, aﬀording ligand 30. A one-pot synthesis using (p-
cymene)ruthenium(II) chloride dimer 30 and bpy provided
complex 31. Reaction of ligand 26 (Scheme 3) with this complex
then gave the ruthenium complex [10](PF6)2.
Demonstrations of the covalent modiﬁcation of the 2-O
position of D-glucose with an alkyl-based linker have been given
by Dumas et al. and Patray and co-workers.14,31 Both groups
chose a similar approach starting from methyl 3,5,6-tri-O-
benzyl-α/β-D-glucofuranoside followed by installment of the
linker and subsequent deprotection of the protection groups
using dihydrogen and palladium on carbon. Sulfur-based linkers,
however, poisoned the palladium catalysts, which made removal
of the benzyl protecting groups impossible following this
approach.22,32 Other methods to remove benzyl groups, such as
Birch reductions, have been reported to cleave thioethers.33
Therefore, all described approaches for the functionalization of
the O-2 position in D-glucose with a metal-binding moiety,
including the glucofuranoside approach described by Schubiger
or Lippard, or the approach via a benzylorthoacetate
intermediate described by Miao et al.34 were found unsuitable
for thioether-containing compounds. We therefore devised a
new protecting group strategy improving the 10-step, 5% yield
procedure published by Lippard et al.14 and employing the α-
oxirane method developed by the group of Danishefsky35,36 and
attempted by Dumas et al. (Scheme 5).31 Using this method, D-
glucal was protected using the p-methoxy benzyl (PMB) group,
aﬀording 34. Treatment of this compound with freshly prepared
dimethyldioxirane (DMDO) aﬀorded its corresponding 1,2-
anhydrosugar, which was then condensed with p-methoxy
benzyl alcohol (PMB−OH) in the presence of anhydrous ZnCl2
in THF, aﬀording β-substituted 35, while simultaneously
liberating the 2-O position. This compound was then treated
Scheme 3a
aReaction conditions: (a) 2-(2-chloroethoxy)ethanol or 2-[2-(2-
chloroethoxy)ethoxy]ethanol, NaSMe in THF, reﬂux, 6 h, 89% for 18,
85% for 19; (b) 2-(methylthio)ethanol, 1,3-bis(methylthio)propanol,
18 or 19, cat. TMSOTf in DCM, 4 Å molecular sieves, rt, 4 h, 81% for
21, 66% for 22, 85% for 23, 90% for 27; (c) NaOMe in MeOH, rt,
88% for 24, 86% for 25, 91% for 26, 70% for 28; (d) [Ru(bpy)2Cl2]
in H2O, 80 °C, 59% for [11]Cl2; (e) [Ru(tpy)(bpy)Cl]Cl in H2O, 80
°C, 39% for [3](PF6)2, 66% for [4](PF6)2, 65% for [5](PF6)2.
Scheme 4a
aReaction conditions: (a) (i) H2O2 in AcOH, 70 °C, 6 h, (ii) H2, Pd/
C, 40 °C, overnight, 24% over two steps; (b) bpy in MeOH, 60 °C,
72%; (c) 25, in H2O, 80 °C, 16 h, 38%.
Scheme 5a
aReaction conditions: (a) 19, TsCl, Et3N in DCM, 0 °C to rt, 16 h,
92%; (b) PMB−Cl, NaH in DMF, 0 °C to rt, 16 h, 84%; (c) (i)
DMDO (0.088 M in acetone) in DCM, 0 °C to rt, 3 h, (ii) PMB−
OH, ZnCl2 in THF, −78 °C to rt, 16 h, 39% over two steps; (d) 32,
NaH in DMF, 0 °C to rt, 6 h, 80%; (e) (i) cat. HCl in HFIP/DCM, 5
min, (ii) MeNH2 in MeOH/H2O, 60 °C, 30 min, 67%; (f)
[Ru(tpy)(bpy)(H2O)](PF6)2 in acetone/H2O, 80 °C, 24 h, 36%.
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with tosylate 32 (Scheme 5) for the installment of the thioether
moiety. This conversion proceeded smoothly, which is in
contrast to the observation of Schubiger et al., who had to divert
to the furanoside approach due to diﬃculties encountered
during the installment of their iminodiacetic acid-based
spacer.31 With compound 36 in hand, a recently described
method37 using 37% hydrochloric acid in hexaﬂuoroisopropanol
(HFIP) was used to remove all four PMB groups simulta-
neously. After the reaction was quenched using Et3N ,an
intermediate species was observed (m/z = 463.4 found, 463.2
calcd) corresponding to the desired product H37 and a PMB
group. This same intermediate was also observed in the presence
of a mild reducing agent such as Et3SiH. However, when this
intermediate was treated with MeNH2 in MeOH,
38 the methyl
thioether could be liberated, acquiring hemiacetal H37 in ﬁve
steps (18% overall yield). After reaction of this compound with
[Ru(tpy)(bpy)(H2O)](PF6)2 glycoconjugate [Ru(tpy)(bpy)-
(37)]PF6, ([6]PF6) was acquired instead of [Ru(tpy)(bpy)-
(H37)](PF6)2. This is most likely due to the relatively protic
nature of the anomeric proton, resulting in deprotonation during
puriﬁcation on Sephadex and replacement of one of the PF6
counterions by the “charged” deprotonated glucose species as
interpreted by elemental analysis. On mass, however, only the
2+ species is observed, indicating that reprotonation occurs in
solution. This behavior was observed for all hemiacetal glucose
derivatives.
The most straightforward thioether functionalization in these
series of ligands was the modiﬁcation of the 3-O position of D-
glucose. Starting from diacetone glucose 38 (Scheme 6),39−41
the thioether moiety was installed using 32 (Scheme 5),
aﬀording compound 39, which was subsequently hydrolyzed
using Amberlite IR-120 H+, aﬀording H40 in 42% overall yield.
Glycoconjugation of H40 with [Ru(tpy)(bpy)Cl]Cl gave the
orange (λmax = 450 nm) complex [Ru(tpy)(bpy)(40)]PF6
([7]PF6).
The 4-O position of D-glucose was modiﬁed starting from
acetobromo-α-D-glucose 40 (Scheme 7). Using a procedure ﬁrst
described by Kaji et al., this building block was converted in situ
to its anomeric iodide, followed by a Koenigs−Knorr-type
glycosylation with p-methoxy benzyl alcohol as an acceptor and
Ag2CO3 as a base.
42 De-O-acetylation furnished intermediate
41, followed by 4,6-O-benzylidenation and installment of PMB
groups, aﬀording fully protected 43. With this building block in
hand, a reductive opening using NaCNBH3 and TFA liberated
the 4-O position, which could then be alkylated via aWilliamson
etheriﬁcation using 32 described in the previous sections,
aﬀording 45. Global deprotection was achieved by treatment
with HFIP/HCl, which gave thioether ligand H46 in an 11%
overall yield. The subsequent reaction of H46 with [Ru(tpy)-
(bpy)(H2O)](PF6)2 aﬀorded glycoconjugate [Ru(tpy)(bpy)
(46)]PF6 ([8]PF6). The synthesis ofH46was also attempted via
an alternative approach using α-methyl glucose following a
similar protecting group strategy. However, this proved to be
unsuccessful due to the inertness of the anomeric methyl acetal
toward acid.
Finally, the 6-O position of D-glucose was easily modiﬁed
starting from dimethyl glucose 48 (Scheme 8),43 which could be
converted to 49 using a Williamson etheriﬁcation with tosylate
32, followed by acid hydrolysis using dilute hydrochloric acid,
aﬀording methyl thioether H50 in 55% over two steps.
Glycoconjugation with [Ru(tpy)(bpy)Cl]Cl aﬀorded [Ru(tpy)-
(bpy)(50)]PF6 ([9]PF6).
■ CONCLUSION
In this work, we have presented eﬃcient and robust routes to all
positional isomers of D-glucose bearing a thioether ligand bound
to a light-cleavable ruthenium(II) polypyridyl complex. The
Scheme 6a
aReaction conditions: (a) 32, NaH in DMF, 0 °C to rt, 16 h, 91%;
(b) Amberlite IR-120 H+ in H2O, 60 °C, 24 h, 46%; (c)
[Ru(tpy)(bpy)Cl]Cl in H2O, 80 °C, 16 h, 37%.
Scheme 7a
aReaction conditions: (a) (i) PMB−OH, I2, Ag2CO3 in Et2O, rt, 24 h,
(ii) NaOMe in MeOH, rt, 4 h, 72% over two steps; (b) α,α,4-
trimethoxytoluene, cat. p-TsOH·H2O in DMF, 60 °C, 16 h, 89%; (c)
PMB−Cl, NaH in DMF, 0 °C to rt, 78%; (d) NaCNBH3, TFA in
DMF, 0 °C to rt, 48 h, 95%; (e) 32, NaH in DMF, 0 °C to rt, 6 h,
78%; (f) cat. HCl in HFIP/DCM, 30 min, 29%; (g) [Ru(tpy)(bpy)-
Cl]Cl in H2O, 80 °C, 64%.
Scheme 8a
a(a) 32, NaH in DMF, 0 °C to rt, 3 h, 78%; (b) 2 M HCl in H2O, 60
°C, 1 h, 70%; (c) [Ru(tpy)(bpy)Cl]Cl in H2O, 80 °C, 16 h, 17%.
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general protecting−deprotecting group strategy presented in
this work is compatible with compounds bearing donor atoms
such as sulfur, without the need of palladium catalysts until ﬁnal
coordination to the functional ruthenium compound. These
routes might possibly be extended to application with other
functionalized ligands, such as carboxylates, amines, or
pyridines. The study of this library of ruthenium(II)
glycoconjugates might shed light on the inﬂuence of the
stereochemistry of glucose functionalization on GLUT-medi-
ated uptake and the metabolism of the ruthenium−glucose
conjugates by enzymes such as hexokinase II.
■ EXPERIMENTAL SECTION
General. Reagents were purchased from Sigma-Aldrich and used
without further puriﬁcation. 2,2′:6′,2″-Terpyridine (tpy) was ordered
from ABCR GmbH & Co. Dry solvents were collected from a Pure
Solve MD5 solvent dispenser fromDemaco. For all inorganic reactions,
solvents were deoxygenated by bubbling dinitrogen through the
solution for 30 min. All organic reactions were carried out under a
diniotrogen atmosphere at rt. Flash chromatography was performed on
silica gel (Screening devices B.V.) with a particle size of 40−64 μM and
a pore size of 60 Å. TLC analysis was conducted onTLC aluminum foils
with a silica gel matrix (Supelco, silica gel 60, 56524) with detection by
UV absorption (254 nm), by spraying with 10% H2SO4 in ethanol or
with a solution of NH4Mo7O24·4H2O (25 g/L), NH4CeSO4·H2O (10
g/L), 10%H2SO4 inH2O, followed by charring at∼250 °Con a heating
plate. Optical rotation measurements were performed on a Propol
automated polarimeter (sodium D line, λ = 589 nm) with a
concentration of 10 mg/mL (c = 1) unless stated otherwise. Infrared
spectra were recorded on a PerkinElmer UATR (Single Reﬂection
Diamond) SpectrumTwo device (4000−700 cm−1; resolution 4 cm−1).
1H NMR and 13C NMR were recorded in CD3OD and CDCl3 with a
chemical shift (δ) relative to the solvent peak on a Bruker AV 400 or AV
500 unit. High-resolution mass spectra were recorded by direct
injection (2 μL of 2 μM solution in water/acetoneitrile; 50/50; v/v and
0.1% formic acid) in a mass spectrometer (Thermo Finnigan LTQ
Orbitrap) equipped with an electrospray (250 °C) with a resolution
(R) = 60 000 at m/z 400 (mass range m/z = 150−2000) and
dioctylphtalate (m/z = 391.28428) as a lock mass. The high-resolution
mass spectrometer was calibrated prior to measurements with a
calibration mixture (Thermo Finnigan). Melting point ranges were
determined on a Stuart SMP30 unit. Elemental analysis for
glycoconjugates [1](PF6)2−[5](PF6)2, [6]PF6−[10]PF6, and
[11]Cl2 was performed at Mikrolab Kolbe, Germany.
Synthesis. (2-Methylthio)ethyl-α-D-glucopyranoside (13).
2,3,4,6-Tetra-O-acetyl-(2-bromo)ethyl-α-D-glucopyranoside25 (135
mg, 0.297 mmol) was dissolved in dry DMF (3 mL), and to this
solution was added freshNaSMe (23mg, 0.33mmol). The reaction was
stirred overnight, after which it was diluted with EtOAc (25 mL),
washed with water (2×) and aq NaHCO3 (2×), and dried (Na2SO4).
Concentration in vacuo was followed by puriﬁcation of the residue by
silica column chromatography (10% MeOH in DCM), aﬀording the
title compound (50.0 mg, 0.197 mmol, 66% over two steps) as a
colorless oil: Rf = 0.84 (20% MeOH in DCM); IR (neat) 3350, 2918,
1639, 1426, 1018; 1H NMR (400 MHz, CD3OD) δ 4.80 (d, J = 3.8 Hz,
1H, H-1), 3.91−3.75 (m, 2H, CHHH-6, CHHOCH2), 3.69−3.58 (m,
4H, H-4, H-5, CHH H-6, CHH OCH2), 3.37 (dd, J = 9.7, 3.8 Hz, 1H,
H-2), 3.25 (d, J = 9.3 Hz, 1H, H-3), 2.73 (td, J = 6.9, 1.8 Hz, 2H,
OCH2SMe), 2.12 (s, 3H, OCH2SMe);
13C NMR (101 MHz, CD3OD)
δ 100.3 (C-1), 75.1 (C-4), 73.9 (C-5), 73.5 (C-2), 71.8 (C-3), 68.4
(OCH2), 62.7 (C-6), 34.3 (OCH2SMe), 15.8 (OCH2SMe); HRMS
(ESI) m/z [M + Na]+ calcd for C9H18O6SNa 277.0716, found
277.0711.
Methylthio-β-D-glucopyranoside (15). α/β-D-Glucose pentaacetate
(4.99 g, 12.4 mmol) was dissolved in anhydrous DCM (20 mL), and to
this solution were added I2 (4.84 g, 19.0 mmol) and Et3SiH (2.90 mL,
18.2 mmol). This mixture was allowed to stir for 10 min, after which it
was diluted with DCM (100 mL) and washed with aqueous saturated
Na2S2O3 (1×) and Na2CO3 (1×). Layers were separated, and the
organic layer was dried (Na2SO4) and concentrated in vacuo. The crude
was coevaporated with toluene (3×) and redissolved in dry MeCN (20
mL), followed by the addition of thiourea (1.46 g, 19.2 mmol). The
mixture was then heated for 30 min at 80 °C, after which it was allowed
to cool down to rt, followed by the addition of MeI (1.60 mL, 25.7
mmol) and Et3N (7.10 mL, 50.9 mmol). After an additional stirring for
10 min, the mixture was concentrated in vacuo, followed by puriﬁcation
of the residue over silica (0 to 50% Et2O in PE), yielding methyl 2,3,4,6-
tetra-O-acetyl-1-thio-β-D-glucopyranoside as a yellow foam (2.71 g,
7.24 mmol). This compound was then dissolved in dryMeOH (70mL)
followed by the addition of a catalytic amount of NaOMe, which after
stirring overnight was quenched upon the addition of Amberlite IR-120
H+. Filtration was followed by concentration in vacuo, yielding the title
compound as a colorless oil (1.48 g, 7.04mmol, 57% over four steps):Rf
= 0.63 (20%MeOH inDCM); IR (neat) 3336, 2923, 2881, 1425, 1017;
1HNMR (400MHz, CD3OD) δ 4.35 (d, J = 9.6Hz, 1H,H-1), 3.93 (d, J
= 11.8 Hz, 1H, CHH H-6), 3.77−3.68 (m, 1H, CHH H-6), 3.48−3.35
(m, 3H, H-3, H-4, H-5), 3.31 (t, J = 9.1 Hz, 1H, H-2), 2.26 (s, 3H,
SMe); 13C NMR (101 MHz, CD3OD) δ 87.1 (C-1), 81.8 (C-3), 79.3
(C-4), 73.5 (C-2), 71.3 (C-5), 62.7 (C-6), 12.0 (SMe); HRMS (ESI)
m/z [M + Na]+ calcd for C7H14O5SNa 233.0454, found 233.0444.
2-(Methylthio)ethoxy)ethanol (18). To a ﬂame-dried round-
bottom ﬂask was added freshly prepared NaSMe44 (1.21 g, 15.5
mmol) under argon. Deoxygenated THF (50 mL) was added, followed
by the addition of 2-chloroethoxy)ethanol (1.50 mL, 14.2 mmol). This
solution was heated at 60 °C for 6 h, after which it was allowed to cool to
room temperature. The mixture was diluted with EtOAc (100 mL) and
washed with aqueous NaHCO3 (2×) and water (1×). The layers were
separated, and the organic layer was dried (Na2SO4) and concentrated
in vacuo, aﬀording a slightly yellowish oil (1.89 g, 13.9 mmol, 89%): IR
(neat) 3480, 2907, 2866, 1611, 1512; 1H NMR (400 MHz, CDCl3) δ
3.68 (m, 2H, CH2), 3.62 (t, J = 6.7 Hz, 2H, CH2), 3.54 (d, J = 5.1 Hz,
2H, CH2), 2.94−2.81 (s, 1H, OH), 2.66 (t, J = 6.6 Hz, 2H, SCH2), 2.10
(s, 3H, CH3);
13CNMR (100MHz, CDCl3) δ 72.1 (CH2), 69.9 (CH2),
61.5 (CH2), 33.6 (SCH2), 15.8 (SCH3); HRMS (ESI) m/z [M + Na]
+
calcd for C5H12O2SNa 159.0450, found 159.0457.
2-[2-(2-(Methylthio)ethoxy)ethoxy]ethanol (19). The procedure
was followed as described for 18 using NaSMe44 (4.23 g, 60.4 mmol)
and 2-[2-(2-chloroethoxy)ethoxy]ethanol (10.0 g, 59.3 mmol). 19 was
aﬀorded as a colorless oil (9.25 g, 51.0 mmol, 85%): IR (neat) 3427,
2915, 2869, 1105, 1063; 1HNMR (400MHz, CDCl3) δ 3.61−3.42 (m,
10H, 5×CH2), 3.09 (s, 1H, OH), 2.60−2.50 (m, 2H, 1×CH2), 2.03−
1.94 (s, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 72.4 (CH2), 70.2
(CH2), 70.1 (CH2), 70.0 (CH2), 61.3 (CH2) 33.13 (SCH2), 15.7
(SCH3); HRMS (ESI) m/z [M + Na]
+ calcd for C7H16O3SNa
203.0712, found 203.0713.
(2-Methylthio)ethyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside
(21). 2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl trichloroacetimi-
date45 (370 mg, 0.364 mmol) and 2-(methylthio)ethanol (100 μL,
1.15 mmol) were coevaporated three times with anhydrous toluene,
after which they were dissolved in anhydrous DCM (36 mL). Freshly
activated 4 Å molecular sieves were added, and the mixture was allowed
to stir for 15 min, after which a catalytic amount of TMSOTf (20.0 μL,
111 μmol) was added. After stirring for 4 h at room temperature, the
reaction was quenched upon the addition of Et3N (100 μL, 0.714
mmol) and concentrated in vacuo followed by puriﬁcation of the
residue over silica (10% to 50% EtOAc in PE), aﬀording the title
compound as a clear oil (270 mg, 0.410 mmol, 81%): Rf = 0.74 (30%
EtOAc in PE); IR (neat) 3064, 2922, 2853, 1720, 1258; 1H NMR (400
MHz, CDCl3) δ 8.07−8.02 (m, 2H, Harom), 8.00−7.96 (m, 2H, Harom),
7.94−7.90 (m, 2H, Harom), 7.87−7.81 (m, 2H, Harom), 7.60−7.25 (m,
12H, Harom), 5.93 (t, J = 9.7 Hz, 1H, H-3), 5.70 (t, J = 9.7 Hz, 1H, H-4),
5.56 (dd, J = 9.8, 7.8 Hz, 1H, H-2), 4.93 (d, J = 7.8 Hz, 1H, H-1), 4.67
(dd, J = 12.2, 3.2 Hz, 1H, CHH H-6), 4.52 (dd, J = 12.1, 5.4 Hz, 1H,
CHHH-6), 4.19 (ddd, J = 8.6, 5.4, 3.2 Hz, 1H, H-5), 4.09 (dt, J = 10.2,
6.7 Hz, 1H, CHHOCH2), 3.78 (dt, J = 10.3, 7.3 Hz, 1H, CHHOCH2),
2.67 (t, J = 6.9 Hz, 2H, CH2SMe), 2.01 (s, 3H, CH2SMe);
13C NMR
(101MHz, CDCl3) δ 166.2 (COBz), 165.9 (COBz), 165.3 (C
O Bz), 165.2 (CO Bz), 133.6 (CH arom), 133.4 (CH arom), 133.3
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(CH arom), 129.9 (CH arom), 129.9 (CH arom), 129.9 (CH arom), 129.8
(CH arom), 129.7 (Cq arom), 129.4 (Cq arom), 128.9 (Cq arom), 128.8
(Cq arom), 128.5 (CH arom), 128.5 (CH arom), 128.5 (CH arom), 128.4
(CH arom), 101.4 (C-1), 73.0 (C-3), 72.4 (C-5), 71.9 (C-2), 69.8 (C-4),
69.8 (OCH2), 63.2 (C-6), 33.4 (CH2SMe), 16.1 (CH2SMe); HRMS
(ESI) m/z [M + NH4]
+ calcd for C37H38O10SN 688.2211, found
688.2222.
[2-(2-(Methylthio)ethoxy)]ethyl 2,3,4,6-tetra-O-benzoyl-β-D-glu-
copyranoside (22). The general procedure described for 21 was
followed, with 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl trichloroa-
cetimidate (6.00 g, 8.14 mmol) and 2-(2-(methylthio)ethoxy)ethanol
(1.24 g, 9.10 mmol). Puriﬁcation of the residue by silica column
puriﬁcation (0−25% EtOAc in PE) aﬀorded the title compound as a
clear oil (3.86 g, 5.40 mmol, 66%): Rf = 0.34 (33% EtOAc in PE); IR
(neat) 3064, 2919, 1722, 1602, 1249; 1H NMR (400 MHz, CDCl3) δ
8.05−8.01 (m, 2H, Harom), 8.00−7.96 (m, 2H, Harom), 7.93−7.88 (m,
2H, Harom), 7.86−7.81 (m, 2H, Harom), 7.58−7.24 (m, 12H, Harom),
5.92 (t, J = 9.7 Hz, 1H, H-3), 5.69 (t, J = 9.7 Hz, 1H, H-4), 5.54 (dd, J =
9.9, 7.7 Hz, 1H, H-2), 4.99 (d, J = 7.8 Hz, 1H, H-1), 4.65 (dd, J = 12.1,
3.2 Hz, 1H, CHHH-6), 4.51 (dd, J = 12.1, 5.1 Hz, 1H, CHHH-6), 4.18
(ddd, J = 10.1, 5.2, 3.1 Hz, 1H, H-5), 4.00 (dt, J = 11.4, 4.1 Hz, 1H,
CHHOCH2), 3.81 (ddd, J = 11.1, 6.9, 3.8 Hz, 1H, CHHOCH2), 3.58
(dt, J = 6.7, 3.7 Hz, 2H, OCH2), 3.48 (t, J = 6.7 Hz, 2H, OCH2), 2.44 (t,
J = 6.7Hz, 2H, CH2SMe), 2.03 (s, 3H, CH2SMe);
13CNMR (101MHz,
CDCl3) δ 166.3 (CO Bz), 165.9 (CO Bz), 165.3 (CO Bz),
165.2 (CO Bz), 133.6 (CH arom), 133.4 (CH arom), 133.3 (CH arom),
129.9 (CH arom), 129.9 (CH arom), 129.9 (CH arom), 129.9 (CH arom),
129.7 (Cq arom), 129.4 (Cq arom), 128.9 (Cq arom), 128.9 (Cq arom), 128.5
(CH arom), 128.5 (CH arom), 128.4 (CH arom), 101.4 (C-1), 73.0 (C-3),
72.3 (C-5), 72.0 (C-2), 70.6 (OCH2), 70.2 (OCH2), 69.8 (C-4), 69.4
(OCH2), 63.2 (C-6), 33.5 (CH2SMe), 16.1 (CH2SMe); HRMS (ESI)
m/z [M + NH4]
+ calcd for C39H42O11SN 732.2473, found 732.2484.
2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl 2,3,4,6-tetra-O-benzoyl-
β-D-glucopyranoside (23).The general procedure described for 21was
followed, with 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl trichloroa-
cetimidate45 (2.65 g, 3.58 mmol) and 19 (792 mg, 4.39 mmol).
Puriﬁcation of the residue over silica (10% to 50% EtOAc in PE)
aﬀorded the title compound as a clear oil (2.32 g, 3.06mmol, 85%): Rf =
0.16 (20% EtOAc in PE); [α]D
20 (CHCl3) +18.0; IR (neat) 3063, 2918,
2869, 1722, 1451; 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.6 Hz,
2H, Harom), 7.97 (d, J = 8.6 Hz, 2H, Harom), 7.90 (d, J = 8.7 Hz, 2H, 2H,
Harom), 7.83 (d, J = 8.6 Hz, 2H, Harom), 7.58−7.43 (m, 3H, Harom),
7.43−7.29 (m, 7H, Harom), 7.29−7.21 (m, 2H, Harom), 5.93 (t, J = 9.7
Hz, 1H, H-3), 5.70 (t, J = 9.7 Hz, 1H, H-4), 5.55 (dd, J = 9.7, 7.8 Hz,
1H, H-2), 5.01 (d, J = 7.8 Hz, 1H, H-1), 4.66 (dd, J = 12.1, 3.1 Hz, 1H,
CHH H-6), 4.51 (dd, J = 12.1, 5.1 Hz, 1H, CHH H-6), 4.20 (ddd, J =
9.9, 5.1, 3.1 Hz, 1H, H-5), 4.03−3.95 (m, 1H, CHHOCH2), 3.83 (m,
1H, CHHOCH2), 3.69−3.56 (m, 2H, OCH2), 3.55 (t, J = 6.9 Hz,
2H, OCH2), 3.50−3.42 (m, 2H, OCH2), 3.37 (t, J = 4.6 Hz, 2H,
OCH2), 2.64 (t, J = 6.9 Hz, 2H, CH2SMe), 2.11 (s, 3H, SCH3);
13C
NMR (101 MHz, CD3OD) δ 166.1 (CO Bz), 165.8 (CO Bz),
165.2 (CO Bz), 165.1 (CO Bz), 133.5 (CHarom), 133.3 (CHarom),
133.2 (CHarom), 129.8 (CHarom), 129.8 (CHarom), 129.6 (Cq arom),
129.4 (Cq arom), 128.8 (Cq arom), 128.4 (CHarom), 128.4 (CHarom), 101.3
(C-1), 73.0 (C-3), 72.2 (C-5) 72.0 (C-2), 70.7 (OCH2), 70.5 (OCH2),
70.2 (OCH2), 69.8 (C-4), 69.4 (OCH2), 63.2 (OCH2), 33.4
(CH2SMe), 16.0 (CH2SMe); HRMS (ESI) m/z [M + Na]
+ calcd for
C41H42O12SNa 781.2289, found 781.2280.
(2-Methylthio)ethyl-β-D-glucopyranoside (24). The protected
glucoside 23 (240 mg, 0.410 mmol) was dissolved in MeOH (6 mL),
after which a catalytic amount of NaOMe was added. The solution was
allowed to stir for 16 h, after which Amberlite IR-120 H+ was added,
until a neutral pH. The resin was ﬁltered oﬀ, and the mixture was
concentrated in vacuo. Puriﬁcation of the residue over silica (0 to 10%
MeOH in DCM) aﬀorded the title compound as a colorless oil (80.0
mg, 0.315 mmol, 88%): Rf = 0.15 (5% MeOH in DCM); IR (neat)
3351, 2919, 2881, 1072, 1016; 1H NMR (400 MHz, CD3OD) δ 4.30
(d, J = 7.8 Hz, 1H, H-1), 4.03 (dt, J = 10.1, 7.1 Hz, 1H, CHH OCH2),
3.87 (dd, J = 11.9, 1.8 Hz, 1H, CHHH-6), 3.74 (dt, J = 10.1, 7.1 Hz, 1H,
CHH OCH2), 3.69−3.64 (m, 1H, CHH H-6), 3.39−3.33 (m, 1H, H-
4), 3.29−3.26 (m, 2H, H-3, H-5), 3.21−3.15 (m, 1H, H-2), 2.73 (t, J =
7.1 Hz, 2H, CH2SMe), 2.13 (s, 3H, CH2SMe);
13C NMR (101 MHz,
CD3OD) δ 104.4 (C-1), 77.9 (C-3), 77.9 (C-4), 75.0 (C-2), 71.6 (C-
5), 70.0 (OCH2), 62.7 (C-6), 34.3 (CH2SMe), 15.7 (CH2SMe); HRMS
(ESI) m/z [M + Na]+ calcd for C9H18O6SNa 277.0714, found
277.0716.
[2-(2-(Methylthio)ethoxy)]-ethyl-β-D-glucopyranoside (25). The
procedure as described for 24 was followed, using protected glycoside
22 (560 mg, 0.780 mmol) and THF/MeOH (10 mL, 1:1). Puriﬁcation
of the crude over silica (0 to 20% acetone in DCM) aﬀorded the title
compound as a white solid (200 mg, 0.670 mmol, 86%): Rf = 0.19 (10%
acetone in DCM); IR (neat) 3304, 2919, 1075, 1354, 1028; 1H NMR
(400 MHz, CD3OD) δ 4.31 (d, J = 7.8 Hz, 1H, H-1), 4.05−3.96 (m,
1H, CHH OCH2), 3.87 (dd, J = 11.9, 1.8 Hz, 1H, CHH H-6), 3.78−
3.62 (m, 6H, CHHH-6, CHHOCH2, 2 ×OCH2), 3.40−3.25 (m, 3H,
H-3, H-4, H-5), 3.19 (dd, J = 9.3, 7.5 Hz, 1H, H-2), 2.68 (t, J = 6.8 Hz,
2H, CH2SMe), 2.13 (s, 3H, CH2SMe);
13C NMR (101 MHz, CD3OD)
δ 104.4 (C-1), 78.0 (C-3), 78.0 (C-4), 75.1 (C-2), 71.6 (C-5), 71.5
(OCH2), 71.2 (OCH2), 69.7 (OCH2), 62.8 (C-6), 34.2 (CH2SMe),
15.8 (CH2SMe); mp 89.9−90.8 °C;HRMS (ESI)m/z [M +Na]+ calcd
for C11H22O7SNa 321.0978, found 321.0976.
2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl β-D-glucopyranoside
(26). The protected glucoside 23 (973 mg, 1.28 mmol) was dissolved
in MeOH (10 mL), after which a catalytic amount of NaOMe was
added. The solution was allowed to stir for 16 h, after which Amberlite
IR-120H+ was added, until reaching a neutral pH. The resin was ﬁltered
oﬀ, and the mixture was concentrated in vacuo. Puriﬁcation of the
residue over silica (0−10% MeOH in DCM) aﬀorded the title
compound as a colorless oil (400 mg, 1.17 mmol, 91%): Rf = 0.29 (10%
MeOH in DCM); [α]D
20 (MeOH) −10.0; IR (neat) 3371, 2915, 2874,
1073, 1031; 1H NMR (400 MHz, CDCl3) δ 4.35 (d, J = 7.8 Hz, 1H, H-
1), 4.06 (ddd, J = 10.2, 5.0, 3.0 Hz, 1H, CHHOCH2), 3.90 (dd, J = 11.9,
1.7 Hz, 1H, CHHOCH2), 3.82−3.65 (m, 10H, CHHOCH2, H-5, H-6,
3 × CH2 OCH2), 3.45−3.37 (m, 1H, H-3), 3.37−3.28 (m, 1H, H-4),
3.24 (dd, J = 9.1, 7.8 Hz, 1H, H-2), 2.72 (t, J = 6.8 Hz, 2H, OCH2), 2.17
(s, 3H, SCH3);
13C NMR (101MHz, CD3OD) δ 104.4 (C-1), 77.9 (C-
3), 75.0 (C-4), 71.6 (OCH2), 71.5 (C-5), 71.5 (2 × OCH2), 71.1
(OCH2), 69.6 (OCH2), 62.7 (C-6), 34.2 (CH2SMe), 15.9 (CH2SMe);
HRMS (ESI) m/z [M + Na]+ calcd for C13H26O8SNa 365.1241, found
365.1238
[1,3-Bis(methylthio)]-propyl-2,3,4,6-tetra-O-benzoyl-β-D-gluco-
pyranoside (27).The general procedure described for 21was followed,
with 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl trichloroacetimidate
(5.00 g, 6.75 mmol) and 1,3-bis(methylthio)propanol (830 μL, 6.09
mmol). Puriﬁcation of the residue by silica column puriﬁcation (0−20%
EtOAc in PE) aﬀorded the title compound as a clear oil (3.95 g, 5.40
mmol, 90%): Rf = 0.55 (20% EtOAc in PE); IR (neat) 2919, 2853,
1722, 1601, 1259; 1H NMR (400 MHz, CDCl3) δ 8.07−8.00 (m, 2H,
Harom), 7.99−7.94 (m, 2H, Harom), 7.91 (d, J = 7.8 Hz, 2H, Harom),
7.85−7.79 (m, 2H, Harom), 7.60−7.24 (m, 12H, Harom), 5.91 (t, J = 9.7
Hz, 1H, H-3), 5.65 (t, J = 9.7 Hz, 1H, H-4), 5.52 (dd, J = 10.1, 7.7 Hz,
1H, H-2), 5.09 (d, J = 7.9 Hz, 1H, H-1), 4.67 (dd, J = 12.1, 3.1 Hz, 1H,
CHH H-6), 4.48 (dd, J = 12.2, 5.6 Hz, 1H, CHH H-6), 4.18 (ddd, J =
9.3, 5.7, 3.0 Hz, 1H, H-5), 4.04−3.91 (m, 1H, CH(CH2SMe)2), 2.86
(dd, J = 13.8, 4.4 Hz, 1H, CHH CH(CH2SMe)2), 2.81−2.71 (m, 2H,
CH2 CH(CH2SMe)2), 2.61 (td, J = 13.5, 7.4 Hz, 1H, CHH
CH(CH2SMe)2), 2.06 (s, 3H, SMe), 1.90 (s, 3H, SMe);
13C NMR
(101MHz, CDCl3) δ 166.2 (COBz), 165.9 (COBz), 165.4 (C
O Bz), 165.3 (CO Bz), 133.6 (CH arom), 133.4 (CH arom), 133.4
(CH arom), 133.3 (CH arom), 130.0 (CH arom), 129.9 (CH arom), 129.9
(CH arom), 129.9 (CH arom), 129.6 (Cq arom), 129.5 (Cq arom), 128.9
(Cq arom), 128.8 (Cq arom), 128.6 (CH arom), 128.4 (CH arom), 101.7 (C-
1), 80.2 (CH(CH2SMe)2), 73.0 (C-3), 72.4 (C-5), 72.1 (C-2), 69.9 (C-
4), 63.2 (C-6), 38.4 (CH2 CH(CH2SMe)2), 37.8 (CH2 CH-
(CH2SMe)2), 16.7 (2 × SMe); HRMS (ESI) m/z [M + NH4]+ calcd
for C39H42O10S2N 748.2245, found 748.2254.
[1,3-Bis(methylthio)]-propyl-β-D-glucopyranoside (28). The pro-
cedure as described for 22 was followed, using protected glycoside 27
(3.20 g, 4.38 mmol) and DCM/MeOH (50 mL, 1:50). Puriﬁcation of
the residue over silica (0 to 10%MeOH inDCM) aﬀorded 28 as a white
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foam (960 mg, 3.05 mmol, 70%): Rf = 0.24 (100% EtOAc); IR (neat)
3368, 2916, 1424, 1071, 1016; 1H NMR (400 MHz, CD3OD) δ 4.45
(d, J = 7.8 Hz, 1H, H-1), 4.06 (p, J = 5.8 Hz, 1H, CH(CH2SMe)2),
3.90−3.83 (m, 1H, CHH H-6), 3.70−3.63 (m, 1H, CHH H-6), 3.41−
3.33 (m, 1H, H-3), 3.33−3.26 (m, 2H, H-4, H-5), 3.24−3.14 (m, 1H,
H-2), 2.94−2.83 (m, 3H, CHH, CH2 CH(CH2SMe)2), 2.79 (dd, J =
13.8, 5.6 Hz, 1H, CHH CH(CH2SMe)2), 2.15 (s, 6H, 2 × SMe);
13C
NMR (101MHz, CD3OD) δ 104.1 (C-1), 79.4 (CH(CH2SMe)2), 77.9
(C-3), 77.9 (C-4), 75.2 (C-2), 71.5 (C-5), 62.7 (C-6), 39.0 (CH2
CH(CH2SMe)2) 37.9 (CH2 CH(CH2SMe)2), 16.6 (SMe), 16.4
(SMe); HRMS (ESI) m/z [M + Na]+ calcd for C11H22O6S2Na
337.0750, found 337.0752
[2,2′:6′,2″-Terpyridine]-4′-sulfonic acid (30 (HS-tpy)). [2,2′:6′,2″-
Terpyridine]-4′(1′H)-thione46 (534 mg, 2.01 mmol) was suspended in
acetic acid (6 mL). and to this mixture was added 30% H2O2 (1 mL).
The resulting purple mixture was heated at 70 °C for 12 h and
concentrated in vacuo. The crude was then redissolved in H2O,
followed by the addition of 10% Pd/C (32 mg) and purged with H2 (5
min). After stirring overnight at 40 °C under a H2 atmosphere, the
reaction was ﬁltered over Celite, concentrated, and puriﬁed over silica
(0 to 10% MeOH in DCM), aﬀording the title compound as a bright
yellow powder (151 mg, 0.428 mmol, 24%): Rf = 0.37 (20% MeOH in
DCM); IR (neat) 3391, 3064, 1622, 1398, 1189; 1H NMR (400 MHz,
D2O) δ 8.09 (dd, J = 4.9, 1.9 Hz, 2H, T3, T3″), 7.84 (s, 2H, T3′, T5′),
7.61 (d, J = 7.4 Hz, 2H, T6, T6″), 7.54 (td, J = 7.7, 1.9 Hz, 2H, T4, T4″),
7.15 (ddd, J = 7.4, 5.0, 1.4 Hz, 2H, T5, T5″); 13C NMR (101 MHz,
D2O) δ 154.9 (Cq arom), 152.7 (Cq arom), 152.7 (Cq arom), 148.1 (T3,
T3″), 138.1 (T4, T4″), 124.9 (T5, T5″), 121.8 (T6, T6″), 116.5 (T3,
T3″); HRMS (ESI) m/z [M + H]+ calcd for C15H12N3O3S 314.0594,
found 314.0600.
[Ru(S-tpy)(bpy)(Cl)] (31).Compound 30 (134mg, 0.428 mmol) was
dissolved in MeOH (10 mL), and to this solution was added 100 mg of
washed Amberlite Na+. After the mixture stirred for 5 min at rt, the ion-
exchange resin was ﬁltered oﬀ and the ﬁltrate was concentrated in
vacuo, aﬀording a pinkish solid. This compound was then together with
dichloro(p-cymene)ruthenium(II) dimer (130 mg, 0.213 mmol)
redissolved in deoxygenated MeOH (5 mL) and heated to 60 °C. A
solution of bpy (69.0 mg, 0.440 mmol) in MeOH (2.3 mL) was then
added dropwise over 10 min from which the color of the solution
changed from purple to red. After stirring for 2 h under nitrogen, the
solution was allowed to cool to rt, after which Et2O (20mL) was added.
The resulting precipitate was ﬁltered and washed with Et2O (3×),
aﬀording a brown powder (185 mg, 0.306 mmol, 72%): Rf = 0.29 (10%
MeOH in DCM); mp > 350 °C; HRMS (ESI) m/z [M + H]+ calcd for
C25H19ClN5O3RuS 605.9935, found 605.9946.
2-(2-(2-(Methylthio)ethoxy)ethoxy)ethyl 4-methylbenzenesulfo-
nate (32). Compound 19 (715 mg, 3.97 mmol) was dissolved in dry
DCM (40 mL), and the mixture was cooled to 0 °C. To this solution
were added Et3N (850 ul, 6.09 mmol) and Ts-Cl (1.12 g, 5.87 mmol).
The reaction was allowed to stir overnight, after which it was diluted
with DCM (100 mL) and transferred to a separatory funnel. After
washing with water (1×) and brine (1×), the layers were separated, and
the organic layer was dried (Na2SO4) and concentrated in vacuo.
Puriﬁcation of the residue by silica column chromatography (0 to 50%
EtOAc in PE) aﬀorded the title compound as a colorless oil (1.22 g,
3.64 mmol, 92%): Rf = 0.78 (50% EtOAc in PE); IR (neat) 2917, 2868,
1598, 1353, 1174; 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz,
2H, Harom), 7.30 (d, J = 8.1 Hz, 2H, Harom), 4.18−4.02 (m, 2H, CH2),
3.65−3.61 (m, 2H, CH2), 3.57 (t, J = 6.8 Hz, 2H, CH2), 3.51 (m, 4H, 2
× CH2), 2.60 (t, J = 6.8 Hz, 2H, CH2), 2.39 (s, 3H, CH3 tosyl), 2.07 (s,
3H, CH3);
13C NMR (100 MHz, CDCl3) δ 144.7 (Cq arom), 132.7
(Cq arom), 129.7 (CH arom), 127.7 (CH arom), 70.5 (CH2), 70.4 (CH2),
70.0 (CH2), 69.2 (CH2), 68.5 (CH2), 33.2 (SCH2), 21.5 (CH3 tosyl),
15.8 (SCH3); HRMS (ESI) m/z [M + Na]
+ calcd for C14H22O5S2Na
357.0801, found 357.0800.
3,4,6-Tri-O-(4-methoxybenzyl)-D-glucal (34). To a cooled solution
(0 °C) of D-glucal in dry DMF (230 mL) was slowly added NaH (60%
dispersion inmineral oil, 3.10 g, 77.5 mmol) followed by the addition of
4-methoxybenzyl chloride (10.1 mL, 74.5 mmol). After the mixture
stirred overnight under a dinitrogen atmosphere, H2O (10 mL) was
added and the mixture was allowed to stir for another 10 min. The
mixture was further diluted with EtOAc (200 mL), transferred to a
separatory funnel, and washed with water (3×) and brine (3×). The
organic layer was dried over Na2SO4 and concentrated in vacuo.
Puriﬁcation by silica column chromatography (0 to 15% EtOAc in PE)
aﬀorded 34 (9.82 g, 19.4 mmol, 84%) as a clear oil that solidiﬁed upon
standing over a longer time: Rf = 0.66 (10% EtOAc in PE); IR (neat)
2999, 2863, 2907, 1647, 1512; 1HNMR (400MHz, CDCl3) δ 7.16 (d, J
= 8.3 Hz, 4H, Harom), 7.04 (d, J = 8.5 Hz, 2H, Harom), 6.75 (dd, J = 11.9,
8.1 Hz, 6H, Harom), 6.31 (d, J = 6.2 Hz, 1H, H-1), 4.74 (dd, J = 6.2, 3.2
Hz, 1H, H-2), 4.64 (d, J = 10.9 Hz, 1H, CHH PMB), 4.52−4.35 (m,
5H, CHH PMB, 2 × CH2 PMB), 4.07 (dd, J = 6.5, 2.2 Hz, 1H, H-3),
3.92 (dt, J = 8.6, 4.1 Hz, 1H, H-5), 3.70 (s, 3H, CH3 PMB), 3.69 (s, 4H,
CH3 PMB, H-4), 3.69 (s, 3H, CH3 PMB), 3.66−3.58 (m, 2H, CH2 H-
6); 13C NMR (101 MHz, CDCl3) δ 159.3 (CH arom), 159.3 (CH arom),
159.3 (CH arom), 144.7 (C-1), 130.6 (Cq arom), 130.4 (Cq arom), 130.1
(Cq arom), 129.7 (CH arom), 129.6 (CH arom), 129.5 (CH arom), 113.9
(CH arom), 113.9 (CH arom), 100.2 (C-2), 76.9 (C-5), 75.6 (C-2), 74.2
(C-4), 73.5 (CH2 PMB), 73.2 (CH2 PMB), 70.3 (CH2 PMB), 68.3 (C-
6), 55.4 (3 × CH3 PMB); HRMS (ESI) m/z [M + NH4]
+ calcd for
C30H38O7N 524.2643, found 524.2655.
(4-Methoxybenzyl)-3,4,6-Tri-O-(4-methoxybenzyl)-β-D-glucopyr-
anoside (35). To a solution of protected glycoside 35 (821 mg, 1.62
mmol) in dry DCM (8mL) under a dinitrogen atmosphere were added
freshly activated 4 Å molecular sieves. After stirring for 15 min, the
mixture was allowed to cool to 0 °C and freshly prepared
dimethyldioxirane in acetone (20 mL, 88 mM) was slowly added.
The mixture was stirred for 3 h and allowed to reach rt, after which it
was ﬁltered over Celite and concentrated in vacuo. The crude was then,
together with 4-methoxyl benzyl alcohol (335 mg, 2.42 mmol),
redissolved in dry THF under a dinitrogen atmosphere, followed by the
addition of freshly activated 4 Å molecular sieves. After stirring for 15
min, the mixture was cooled down to−78 °C and a cooled solution (10
°C) of ZnCl2 in dry THF (2.43 mL, 1 M) was added dropwise over 10
min. The mixture was allowed to stir overnight at rt, after which it was
ﬁltered over Celite, concentrated in vacuo, and puriﬁed by silica column
chromatography (0 to 20% EtOAc in PE) to aﬀord 35 (413 mg, 0.625
mmol, 39% over two steps) as a colorless oil: Rf = 0.48 (40% EtOAc in
PE); IR (neat) 3480, 3000, 2907, 1611, 1511; 1H NMR (400 MHz,
CDCl3) δ 7.30 (dd, J = 8.5, 4.8 Hz, 6H, Harom), 7.08 (d, J = 8.6 Hz, 2H,
Harom), 6.98−6.77 (m, 8H, Harom), 4.87 (dd, J = 15.4, 11.2 Hz, 2H, CH2
PMB), 4.76 (dd, J = 10.7, 6.4 Hz, 2H, CH2 PMB), 4.63−4.42 (m, 4H, 2
× CH2 PMB), 4.32 (d, J = 7.3 Hz, 1H, H-1), 3.80 (s, 6H, 2 × CH3
PMB), 3.79 (s, 3H, CH3 PMB), 3.79 (s, 3H, CH3 PMB), 3.70 (m, 2H,
H-6), 3.62−3.50 (m, 3H, H-2, H-3, H-4), 3.45 (dd, J = 9.9, 4.1 Hz, 1H,
H-5), 2.41 (s, 1H, OH); 13C NMR (101 MHz, CDCl3) δ 159.5
(Cq arom), 159.3 (Cq arom), 159.3 (Cq arom), 130.9 (Cq arom), 130.4
(Cq arom), 130.3 (Cq arom), 130.0 (CH arom), 129.7 (CH arom), 129.7
(CH arom), 129.6 (CH arom), 129.3 (Cq arom), 114.0 (CH arom), 113.9
(CH arom), 113.9 (CH arom), 101.5 (C-1), 84.3 (C-2), 77.4 (C-3), 75.3
(C-4), 74.9 (CH2 PMB), 74.7 (C-5), 73.2 (CH2 PMB), 70.8 (CH2
PMB), 68.5 (C-6), 55.4 (4 × CH3 PMB); HRMS (ESI) m/z [M +
NH4]
+ calcd for C38H48O10N 678.3273, found 678.3302.
(4-Methoxybenzyl)-2-O-(2-[2-(2-(methylthio)ethoxy)ethoxy]-
ethyl)-3,4,6-tetra-O-(4-methoxybenzyl)-β-D-glucopyranoside (36).
Glycoside 35 (333 mg, 0.504 mmol) was dissolved in dry DMF (5
mL) and cooled to 0 °C. To this solution was added NaH (60%
dispersion in mineral oil, 26 mg, 0.65 mmol) portionwise followed by
the addition of tosylate 32 (185 mg, 0.554 mmol). After the mixture
stirred for 6 h at rt under a dry atmosphere, MeOH was added (1 mL).
The mixture was then diluted with EtOAc (50 mL), transferred to a
separatory funnel, and washed with water (3×) and brine (3×). The
organic layer was dried (Na2SO4) and concentrated in vacuo.
Puriﬁcation of the residue by column chromatography (0 to 30%
EtOAc in PE) aﬀorded the title compound 36 as a milky oil (334 mg,
0.405 mmol, 80%): Rf = 0.39 (40% EtOAc in PE); IR (neat) 2999,
2864, 2835, 1612, 1512; 1HNMR (400MHz, CDCl3) δ 7.39−7.18 (m,
6H, Harom), 7.07 (dd, J = 8.7, 4.8 Hz, 2H, Harom), 6.92−6.75 (m, 8H,
Harom), 4.96−4.80 (m, 2H, CH2 PMB), 4.78−4.66 (m, 2H, CH2 PMB),
4.62−4.37 (m, 5H, CH2 PMB, H-1), 4.06 (dt, J = 9.9, 4.6 Hz, 1H, CHH
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OCH2), 3.85 (q, J = 5.2Hz, 1H, CHHOCH2), 3.81 (s, 3H, CH3 PMB),
3.80 (s, 3H, CH3 PMB), 3.79 (s, 3H, CH3 PMB), 3.79 (s, 3H, CH3
PMB), 3.74−3.66 (m, 2H, H-6), 3.66−3.53 (m, 9H, H-3, 4 × OCH2),
3.49 (t, J = 9.2 Hz, 1H, H-4), 3.40 (ddd, J = 9.7, 5.1, 2.2 Hz, 1H, H-5),
3.29 (t, J = 8.3 Hz, 1H, H-2), 2.62 (t, J = 7.0 Hz, 2H, CH2SMe), 2.10 (s,
3H, CH2SMe);
13C NMR (101 MHz, CDCl3) δ 159.3 (Cq arom),
159.3 (Cq arom), 159.3 (Cq arom), 159.3 (Cq arom), 131.1 (Cq arom),
130.5 (Cq arom), 130.4 (Cq arom), 129.8 (CH arom), 129.7 (CH arom),
129.7 (CH arom), 129.6 (CH arom), 113.8 (CH arom), 102.1 (C-1),
84.4 (C-4), 83.3 (C-2), 77.6 (C-4), 75.3 (CH2 PMB), 74.9 (C-5), 74.7
(CH2 PMB), 73.2 (CH2 PMB), 72.1 (OCH2), 70.9 (OCH2), 70.9
(CH2 PMB), 70.6 (OCH2), 70.5 (OCH2), 70.4 (OCH2), 68.7 (C-6),
55.4 (4 × CH3 PMB), 33.4 (CH2SMe), 16.1 (CH2SMe); HRMS (ESI)
m/z [M + NH4]
+ calcd for C45H62O12SN 840.3987, found 840.4002.
2-O-(2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl)-α/β-D-glucopyra-
noside (H37).Compound 36 (241 mg, 0.293 mmol) was dissolved in a
mixture of DCM/HFIP (1:1, 3 mL), and to this solution were added 5
drops of 37% HCl in H2O. The color immediately changed to dark red,
and after stirring for 5min, themixture was quenched upon the addition
of Et3N (500 μL, 3.59 mmol). The mixture was then concentrated in
vacuo and redissolved in H2O (5.8 mL), followed by the addition of a
solution of MeNH2 in MeOH (145 μL, 2M, 0.29 mmol). After the
reaction mixture was heated for 30 min at 60 °C, the solvents were
removed under reduced pressure and the resulting residue was puriﬁed
by silica column chromatography (0 to 20%MeOH in DCM) to aﬀord
the fully deprotected hemiacetal H37 (67 mg, 0.196 mmol, 67%) as a
clear oil: Rf = 0.54 (25%MeOH in DCM); IR (neat) 3411, 2917, 2865,
1115, 1042; 1H NMR (400 MHz, CD3OD) δ 5.29 (d, J = 3.5 Hz, 1H,
H-1α), 4.53 (d, J = 7.8 Hz, 1H, H-1β), 4.04 (dt, J = 11.3, 4.4 Hz, 1H,
CHH H-6), 3.89−3.70 (m, 8H), 3.70−3.59 (m, 19H), 3.42−3.32 (m,
1H, H-3β), 3.30−3.20 (m, 2H), 3.03−2.86 (m, 1H, H-2β), 2.68 (t, J =
6.8 Hz, 4H, 2 × CH2SMe), 2.13 (s, 6H, 2 × CH2SMe);
13C NMR (101
MHz, CD3OD) δ 98.1 (C-1β), 91.8 (C-1α), 85.1 (C-1β), 82.4, 77.9,
77.5, 73.9, 72.8, 72.6, 71.9, 71.9, 71.6, 71.6, 71.5, 71.5, 71.4, 71.2, 71.1,
71.0, 62.8 (C-6α), 62.7 (C-6β), 34.2 (2 × CH2SMe), 15.9 (2 ×
CH2SMe); HRMS (ESI) m/z [M + Na]
+ calcd for C13H26O8SNa
365.1241, found 365.1251.
1,2:5,6-Di-O-isopropylidene-3-O-(2-[2-(2-(methylthio)ethoxy)-
ethoxy]ethyl)-α-D-glucofuranose (38). To a cooled solution of
diacetone glucose (200 mg, 0.768 mmol) in dry DMF (8 mL) was
added 60%NaH in mineral oil (80.0 mg, 2.00 mmol). After the mixture
stirred for 5 min, tosylate 32 was added and the mixture was left
overnight. After the reaction was quenched with MeOH (1 mL), Et2O
(50 mL) was added and the reaction was transferred to a separatory
funnel. After the mixture was washed with water (1×), aq NaHCO3
(1×), and brine (1×), the layers were separated and the organic layer
was dried (Na2SO4) and concentrated in vacuo. Puriﬁcation of the
residue over silica (0−50% EtOAc in PE) gave 38 as a clear oil. (294
mg, 0.700 mmol, 91%): Rf = 0.73 (50% EtOAc in PE); IR (neat) 2985,
2871, 1456, 1371, 1058; 1HNMR (400MHz, CDCl3) δ 5.87 (d, J = 3.8
Hz, 1H, H-1), 4.57 (d, J = 3.6 Hz, 1H, H-2), 4.31 (dt, J = 7.8, 5.9 Hz,
1H, H-5), 4.14−4.10 (m, 1H, H-3), 4.09−4.05 (m, 1H, CHH H-6),
3.99 (dd, J = 8.6, 5.8 Hz, 1H, CHHH-6), 3.92 (d, J = 3.1 Hz, 1H, H-4),
3.79−3.71 (m, 2H, OCH2), 3.68−3.60 (m, 8H, 4×OCH2), 2.69 (t, J =
6.9 Hz, 2H, CH2SMe), 2.14 (s, 3H, CH2SMe), 1.49 (d, J = 2.7 Hz, 3H,
CH3 isopropylidene), 1.42 (s, 3H, CH3 isopropylidene), 1.34 (s, 3H,
CH3 isopropylidene), 1.31 (d, J = 3.6 Hz, 3H, CH3 isopropylidene);
13C NMR (101 MHz, CDCl3) δ 111.9 (Cq isopropylidene), 109.0 (Cq
isopropylidene), 105.4 (C-1), 82.8 (C-2), 82.7 (C-4), 81.2 (C-3), 72.7
(C-5), 70.8 (OCH2), 70.7 (OCH2), 70.6 (OCH2), 70.5 (OCH2), 70.28,
67.3 (C-6), 33.5 (CH2SMe), 27.0 (CH3 isopropylidene), 27.0 (CH3
isopropylidene), 26.4 (CH3 isopropylidene), 25.6 (CH3 isopropyli-
dene), 16.2 (CH2SMe); HRMS (ESI) m/z [M + NH4]
+ calcd for
C19H38O8SN 440.2313, found 440.2320.
3-O-(2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl)-α/β-D-glucopyra-
noside (H40). To a suspension of compound 38 in H2O was added
Amberlite IR-120 H+, and this mixture was stirred for 24 h at 60 °C,
after which it was ﬁltered and concentrated in vacuo. Puriﬁcation of the
residue over silica (0 to 10% MeOH in DCM) aﬀorded the title
compoundH40 as a clear oil (α/β = 1:1, 81 mg, 0.24 mmol, 46%): Rf =
0.32 (10% MeOH in DCM); IR (neat) 3369, 2918, 2873, 1104, 1077;
1H NMR (400 MHz, CD3OD) δ 5.08 (d, J = 3.6 Hz, 1H, H-1α), 4.47
(d, J = 7.7 Hz, 1H, H-1β), 4.24−3.13 (m, 40H), 2.67 (t, J = 6.9 Hz, 4H,
2 × CH2SMe), 2.11 (s, 6H, 2 × CH2SMe); 13C NMR (101 MHz,
CD3OD) δ 98.1 (C-1β), 94.0 (C-1α), 87.6, 84.5, 77.8, 76.1, 73.7, 73.1,
73.0, 72.2, 72.1, 71.6, 71.4, 71.4, 71.3, 71.1, 62.8 (C-6β), 62.6 (C-6α),
34.2 (2 ×OCH2SMe), 15.9 (2 ×OCH2SMe); HRMS (ESI)m/z [M +
Na]+ calcd for C13H26O8SNa 365.1241, found 365.1243.
(4-Methoxybenzyl)-β-D-glucopyranoside (41). To a solution of
2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide (3.00 g, 7.30 mmol)
and 4-methoxybenzyl alcohol (5.04 g, 36.5 mmol) in dry Et2O (75 mL)
were added freshly activated 4 Åmolecular sieves. The resultingmixture
was allowed to stir for 10 min, after which Ag2CO3 (6.00 g, 21.8 mmol)
and I2 (1.85 g, 7.30 mmol) were added. After the mixture stirred an
additional 24 h under a dinitrogen atmosphere at rt in the dark, the
reactionmixture was ﬁltered over Celite, diluted with EtOAc (200mL),
and washed with 1 M Na2S2O3 (3×), aq NaHCO3 (3×), and brine
(3×). The organic layer was dried (Na2SO4) and concentrated in vacuo.
Puriﬁcation of the residue by silica column chromatography (20%
EtOAc in DCM) aﬀorded (4-methoxybenzyl)-2,3,4,6-tetra-O-acetyl-β-
D-glucopyranoside (2.39 g), which was then redissolved in dry MeOH
(70mL) followed by the addition of a catalytic amount of NaOMe. The
resulting mixture was allowed to stir for 4 h, after which Amberlite IR-
120 H+ was added until a neutral pH, ﬁltered, and concentrated in
vacuo, aﬀording the title compound 41 as a clear oil (1.57 g, 5.23 mmol,
72% over two steps): Rf = 0.57 (20%MeOH in DCM); IR (neat) 3335,
2924, 1612, 1027, 819; 1HNMR (400MHz, CD3OD) δ 7.32 (d, J = 8.6
Hz, 2H, Harom), 6.95−6.71 (m, 2H, Harom), 4.85 (d, J = 18.0 Hz, 1H,
CHH PMB), 4.58 (d, J = 11.3 Hz, 1H, CHH PMB), 4.31 (d, J = 7.8 Hz,
1H, H-1), 3.89 (dd, J = 12.0, 2.2 Hz, 1H, CHHH-6), 3.68 (dd, J = 12.0,
5.5 Hz, 1H, CHH H-6), 3.42−3.14 (m, 4H, H-2, H-3, H-4, H-5); 13C
NMR (101 MHz, CD3OD) δ 160.8 (Cq arom), 130.9 (CH arom), 130.9
(Cq arom), 114.6 (CH arom), 102.9 (C-1), 78.0 (C-3), 78.0 (C-4), 75.1
(C-2), 71.7 (C-5), 71.4 (CH2 PMB), 62.8 (C-6), 55.7 (CH3 PMB);
HRMS (ESI) m/z [M + Na]+ calcd for C14H20O7Na 323.1107, found
323.1088.
(4-Methoxybenzyl)-4,6-O-(4-methoxybenzylidene)-β-D-glucopyr-
anoside (42). To a solution of 41 (309 mg, 1.03 mmol) in dry DMF (5
mL) were added 4-methoxybenzaldehyde dimethyl acetal (135 μL,
0.793 mmol) and p-TsOH·H2O (10 mg, 0.05 mmol). The resulting
reaction mixture was heated at 60 °C for 16 h, after which it was
concentrated in vacuo. Saturated aqueous NaHCO3 (50 mL) was
added, and the mixture was further diluted with EtOAc (200 mL) and
transferred to a separatory funnel. After the mixture was washed with aq
NaHCO3 (3×), water (3×) and brine (3×), the layers were separated,
and the organic layer was dried (Na2SO4) and concentrated in vacuo.
Compound 43 (382 mg, 0.910 mmol, 89%) was obtained after silica
column chromatography (0 to 10% MeOH in DCM) as a white
powder: Rf = 0.48 (10%MeOH in DCM); IR (neat) 3480, 2869, 1612,
1516, 1244; 1H NMR (400 MHz, CD3CN) δ 7.39 (d, J = 8.8 Hz, 2H,
Harom), 7.31 (d, J = 8.7 Hz, 2H, Harom), 7.00−6.86 (m, 4H, Harom), 5.50
(s, 1H, CH PMB acetal), 4.76 (d, J = 11.5 Hz, 1H, CHHPMB), 4.55 (d,
J = 11.5 Hz, 1H, CHH PMB), 4.43 (d, J = 7.8 Hz, 1H, H-1), 4.24 (dd, J
= 10.3, 4.6 Hz, 1H, CHHH-6), 3.78 (s, 6H, 2×CH3 OMe), 3.72 (t, J =
9.9 Hz, 1H, CHH H-6), 3.62−3.50 (m, 1H, H-3), 3.49−3.33 (m, 2H,
H-4, H-5), 3.26 (td, J = 8.1, 3.7 Hz, 1H, H-2); 13C NMR (101 MHz,
CD3CN) δ 161.1 (Cq arom), 160.4 (Cq arom), 131.3 (Cq arom), 130.7
(CH arom), 128.6 (CH arom), 114.6 (CH arom), 114.4 (CH arom), 103.4 (C-
1), 102.1 (CH PMB acetal), 81.6 (C-4), 75.6 (C-2), 74.3 (C-3), 71.4
(CH2 PMB), 69.3 (C-6), 67.2 (C-5), 55.9 (2 × CH3 PMB); HRMS
(ESI) m/z [M + H]+ calcd for C22H27O8 419.1700, found 419.1710.
(4-Methoxybenzyl)-2,3-di-O-(4-methoxybenzyl)-4,6-O-(4-me-
thoxybenzylidene)-β-D-glucopyranoside (43). To a cooled solution
(0 °C) of p-methoxy benzylidene protected 42 (377 mg, 0.900 mmol)
in dry DMF (9 mL) was slowly added NaH (60% dispersion in mineral
oil, 80.0 mg, 2.00 mmol) followed by the addition of 4-methoxybenzyl
chloride (255 μL, 1.89 mmol). After stirring for 5 h under a dinitrogen
atmosphere, the reaction was quenched upon the addition of MeOH (3
mL). The mixture was further diluted with Et2O (200 mL), transferred
to a separatory funnel, and washed with water (1×), aq NaHCO3 (1×),
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and brine (1×). The organic layer was dried over Na2SO4 and
concentrated in vacuo. Puriﬁcation by silica column chromatography (0
to 20% EtOAc in PE) yielded the title compound 43 as a clear oil (447
mg, 0.680 mmol, 76%): Rf = 0.74 (40% EtOAc in PE); IR (neat) 3480,
2869, 1612, 1516, 1244; 1HNMR (400MHz, CDCl3) δ 7.43 (d, J = 8.9
Hz, 2H, Harom), 7.36−7.18 (m, 5H, Harom), 7.00−6.78 (m, 6H, Harom),
5.54 (s, 1H, CH benzylidene), 4.89 (d, J = 11.4 Hz, 1H, CHH PMB),
4.82 (dd, J = 10.8, 5.6 Hz, 2H, CH2 PMB), 4.71 (dd, J = 16.0, 10.7 Hz,
2H, CH2 PMB), 4.65−4.57 (m, 2H, CHH PMB, H-1), 4.37 (dd, J =
10.5, 5.0 Hz, 1H, CHHH-6), 3.82 (s, 6H, 2 × CH3 PMB), 3.82 (s, 3H,
CH3 PMB), 3.80 (s, 3H, CH3 PMB), 3.69 (p, J = 9.1 Hz, 2H, H-3, H-4),
3.49 (t, J = 7.9 Hz, 1H, H-2), 3.40 (td, J = 9.5, 5.0 Hz, 1H, H-5); 13C
NMR (101 MHz, CDCl3) δ 160.1 (Cq arom), 159.5 (Cq arom), 159.3
(Cq arom), 159.3 (Cq arom), 130.8 (Cq arom), 130.6 (Cq arom), 129.9
(CH arom), 129.8 (CH arom), 129.8 (CH arom), 129.3 (Cq arom), 127.4
(CH arom), 113.9 (CH arom), 113.8 (CH arom), 113.7 (CH arom), 103.0 (C-
1), 101.2 (CH PMB acetal), 81.9 (C-2), 81.5 (C-3), 80.7 (C-4), 75.1
(CH2 PMB), 74.9 (CH2 PMB), 71.4 (CH2 PMB), 68.9 (C-6), 66.2 (C-
5), 55.4 (3 × CH3 PMB), 55.3 (CH3 PMB acetal); HRMS (ESI) m/z
[M + Na]+ calcd for C38H42O10Na 681.2670, found 681.2671.
(4-Methoxybenzyl)-2,3,6-tri-O-(4-methoxybenzyl)-β-D-glucopyr-
anoside (44). Fully protected glycoside 43 (400 mg, 0.610 mmol) was
dissolved in DMF (12 mL), and to this solution were added freshly
activated 4 Å molecular sieves and fresh NaCNBH3 (385 mg, 6.13
mmol). After the mixture stirred for 15 min, the solution was cooled to
0 °C, and a precooled solution (0 °C) of triﬂuoroacetic acid (1.2 mL) in
dryDMF (3mL) on 4 Åmolecular sieves was then added dropwise over
15 min. The reaction mixture was maintained at rt for 48 h and ﬁltered
over Celite, diluted with EtOAc (100 mL), and transferred to a
separatory funnel. After washing with water (1×), aq NaHCO3 (1×),
and brine (1×), the organic layer was dried (Na2SO4) and concentrated
in vacuo. Puriﬁcation of the residue by column chromatography over
silica (0 to 30% EtOAc in PE) aﬀorded 44 (385 mg, 0.580 mmol, 95%)
as a clear oil: Rf = 0.48 (40% EtOAc in PE); IR (neat) 3480, 3000, 2907,
1612, 1512; 1HNMR (400MHz, CD3Cl3) δ 7.42−7.16 (m, 8H, Harom),
6.87 (tdd, J = 8.9, 4.7, 2.6 Hz, 8H, Harom), 4.92−4.82 (m, 3H, CHH
PMB, CH2 PMB), 4.67−4.53 (m, 5H, CHHPMB, 2×CH2 PMB), 4.49
(d, J = 7.2 Hz, 1H, H-1), 3.82 (s, 3H, CH3 PMB), 3.81 (s, 3H, CH3
PMB), 3.81 (s, 3H, CH3 PMB), 3.80 (s, 3H, CH3 PMB), 3.79−3.66 (m,
2H, H-6), 3.59−3.51 (m, 1H, H-5), 3.48−3.36 (m, 3H, H-2, H-3, H-4);
13C NMR (101 MHz, CDCl3) δ 159.4 (Cq arom), 152.7 (Cq arom), 152.5
(Cq arom), 130.7 (CH arom), 130.0 (CH arom), 129.9 (CH arom), 129.8
(CH arom), 129.5 (CH arom), 114.1 (CH arom), 113.9 (CH arom), 102.5 (C-
1), 83.8 (C-4), 81.6 (C-2), 75.0 (CH2 PMB), 74.5 (CH2 PMB), 74.2
(C-3), 73.4 (CH2 PMB), 71.7 (C-5), 71.1 (CH2 PMB), 70.2 (C-6),
55.4 (4 × CH3 PMB); HRMS (ESI) m/z [M + NH4]
+ calcd for
C38H48O10N 678.3273, found 678.3321.
(4-Methoxybenzyl)-2-O-(2-[2-(2-(methylthio)ethoxy)ethoxy]-
ethyl)-3,6-tri-O-(4-methoxybenzyl)-β-D-glucopyranoside (45). Com-
pound 44 (300 mg, 0.454 mmol) was dissolved in dry DMF (5 mL),
and the mixture was cooled to 0 °C, after which 60%NaH inmineral oil
(31 mg, 0.77 mmol) was added. This mixture was allowed to stir for 5
min, after which tosylate 32 (177 mg, 0.530 mmol) was added
dropwise. The reaction was allowed to stir for 6 h, after which it was
quenched upon the addition of MeOH (2 mL), diluted with Et2O (20
mL), and transferred to a separatory funnel. After washing with aq
NaHCO3 (1×), water (1×), and brine (1×), the layers were separated,
and the organic layer was dried (Na2SO4) and concentrated in vacuo.
Puriﬁcation of the residue by column chromatography (0 to 40%
EtOAc in PE) aﬀorded the title compound 45 as a clear oil (291 mg,
0.354 mmol, 78%): Rf = 0.38 (40% EtOAc in PE); IR (neat) 2998,
2907, 2836, 1612, 1513; 1HNMR (400MHz, CDCl3) δ 7.36−7.18 (m,
8H, Harom), 6.94−6.79 (m, 8H, Harom), 4.97−4.50 (m, 8H, 4 × CH2
PMB), 4.46 (d, J = 7.8 Hz, 1H, H-1), 3.95 (dt, J = 9.8, 4.5 Hz, 1H, CHH
OCH2), 3.81−3.74 (m, 1H, CHHH-6), 3.76−3.63 (m, 3H, CHHH-6,
2 × CHH OCH2), 3.65−3.50 (m, 8H, H-5, CHH OCH2, 3 × OCH2),
3.46−3.38 (m, 3H, H-2, H-3, H-4), 2.66 (t, J = 6.9 Hz, 2H, CH2SMe),
2.12 (s, 3H, CH2SMe);
13CNMR (101MHz, CDCl3) δ 159.7 (Cq arom),
159.4 (Cq arom), 131.1 (Cq arom), 130.8 (Cq arom), 130.6 (Cq arom), 130.0
(CH arom), 129.8 (CH arom), 129.5 (CH arom), 113.9 (CH arom), 113.8
(CH arom), 102.5 (C-1), 84.3 (C-5), 82.0 (C-2), 78.7 (C-3), 75.4 (CH2
PMB), 75.0 (C-4), 74.6 (CH2 PMB), 73.2 (CH2 PMB), 72.2 (OCH2),
71.0 (CH2 PMB), 70.9 (OCH2), 70.7 (OCH2), 70.6 (OCH2), 70.4
(CH2SMe), 68.8 (C-6), 33.5 (4×CH3 PMB), 16.2 (CH2SMe); HRMS
(ESI) m/z [M + NH4]
+ calcd for C45H62O12SN 840.3987, found
840.4028.
4-O-(2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl)-α/β-D-glucopyra-
noside (H46). Compound 45 (108 mg, 0.131 mmol) was dissolved in a
mixture of DCM/HFIP (1:1, 2 mL), and to this solution were added 4
drops of 37% HCl. The mixture slowly turned red to deep purple in 30
min, after which it was quenched with Et3N (0.5 mL) and concentrated
in vacuo. The crude was redissolved in MeOH (5 mL); Amberlite IR-
120 H+ was added, and the mixture was stirred for 5 min, ﬁltered, and
concentrated. Puriﬁcation of the resulting residue over silica (0 to 15%
MeOH inDCM) aﬀorded the title compoundH46 as a clear oil (13mg,
0.038 mmol, 29%): Rf = 0.57 (20% MeOH in DCM); IR (neat) 3370,
2918, 2873, 1104, 1077; 1H NMR (400 MHz, CD3OD) δ 5.09 (d, J =
3.7 Hz, 1H, H-1α), 4.45 (d, J = 7.7 Hz, 1H, H-1β), 4.02−3.58 (m,
28H), 3.47 (t, J = 8.9 Hz, 1H, H-3β), 3.29−3.19 (m, 2H), 3.13 (dd, J =
9.2, 7.9 Hz, 1H, H-2β), 2.68 (t, J = 6.8 Hz, 4H, 2×OCH2SMe), 2.13 (s,
6H, 2 × OCH2SMe); 13C NMR (100 MHz, CD3OD) δ 98.2 (C-1β),
93.9 (C-1α), 80.5, 80.3, 78.2, 77.0, 76.3, 75.0, 73.9, 72.9, 72.0, 71.7,
71.5, 71.2, 62.5 (C-1β), 62.4 (C-1α), 34.3 (2 × OCH2SMe), 15.9
(OCH2SMe); HRMS (ESI) m/z [M + Na]
+ calcd for C13H26O8SNa
365.1241, found 365.1251.
1,2:3,5-Bis(O-methylidene)-6-O-(2-[2-(2-(methylthio)ethoxy)-
ethoxy]ethyl)α-D-glucofuranose (49). To a cooled (0 °C) solution of
1,2:3,5-bis(O-methylidene)-α-D-glucofuranose (206 mg, 1.00 mmol)
in dry DMF (10 mL) was added 60% NaH in mineral oil (57 mg, 1.42
mmol). After 10min, 19 (385mg, 1.15mmol) was added dropwise, and
the resulting mixture was stirred for 3 h at rt, after which it was
quenched upon the addition of MeOH (2 mL). The reaction mixture
was extracted with Et2O (50 mL) and washed with aq NaHCO3 (2×),
water (2×), and brine (2×). The layers were separated, and the organic
layer was dried (Na2SO4) and concentrated in vacuo. The resulting
residue was then puriﬁed by silica column chromatography (0 to 60%
EtOAc in PE) aﬀording 49 as a colorless oil (286 mg, 0.78 mmol, 78%):
Rf = 0.57 (50% EtOAc in PE); IR (neat) 2867, 1455, 1082, 1184, 1058;
1H NMR (400 MHz, CDCl3) δ 6.03 (d, J = 3.8 Hz, 1H, H-1), 5.12 (d, J
= 5.9 Hz, 1H, CHHmethylene), 5.08 (s, 1H, CH2 methylene), 5.03 (s,
1H, CH2 methylene), 4.78 (d, J = 6.0 Hz, 1H, CHH methylene), 4.46
(d, J = 3.9 Hz, 1H, H-2), 4.37 (d, J = 3.0 Hz, 1H, H-3), 4.14 (t, J = 4.4
Hz, 1H, H-5), 4.03 (d, J = 2.7 Hz, 1H, H-4), 3.85 (dd, J = 10.5, 3.9 Hz,
1H, CHHH-6), 3.75 (dd, J = 10.5, 4.8 Hz, 1H, CHHH-6), 3.64 (dd, J =
11.8, 5.6 Hz, 10H, 4 ×OCH2), 2.69 (t, J = 6.9 Hz, 2H, CH2SMe), 2.14
(s, 3H, CH2SMe);
13C NMR (101 MHz, CDCl3) δ 104.4 (C-1), 96.6
(CH2 methylene), 88.2 (CH2 methylene), 83.9 (C-2), 76.8 (C-3), 76.1
(C-4), 72.5 (C-6), 71.6 (C-5), 71.0 (OCH2), 70.7 (OCH2), 70.7
(OCH2), 70.7 (OCH2), 70.4 (OCH2), 33.5 (OCH2SMe), 16.2
(OCH2SMe); HRMS (ESI) m/z [M + H]
+ calcd for C15H27O8S
367.1421, found 367.1430.
6-O-(2-[2-(2-(Methylthio)ethoxy)ethoxy]ethyl)-α/β-D-glucopyra-
noside (H50). Compound 49 was dissolved in 2 M HCl (5 mL), and
this mixture was heated at 100 °C for 1 h, after which the reaction was
neutralized with 1 M NaOH (10 mL) and concentrated in vacuo.
Puriﬁcation of the residue by silica column chromatography (0 to 20%
MeOH in DCM) aﬀordedH50 as a colorless oil (101 mg, 0.295 mmol,
70%): Rf = 0.50 (20% MeOH in DCM); IR (neat) 3368, 2917, 2874,
1427, 1078; 1H NMR (500 MHz, CD3OD) δ 5.13 (d, J = 3.7 Hz, 1H,
H-1α), 4.52 (d, J = 7.7 Hz, 1H, H-1β), 4.06−3.94 (m, 4H), 3.91−3.87
(m, 1H, CHHH-6α/β), 3.86−3.77 (m, 2H), 3.75−3.64 (m, 20H, 10 ×
OCH2), 3.49−3.38 (m, 3H), 3.41 (ddd, J = 9.8, 8.8, 6.0 Hz, 2H), 3.34−
3.30 (m, 1H), 3.25−3.22 (m, 2H), 2.72 (t, J = 6.8 Hz, 4H, 2 ×
CH2SMe), 2.16 (s, 6H, 2 ×CH2SMe);
13C NMR (126MHz, CD3OD)
δ 98.1 (C-1β), 94.0 (C-1α), 87.6, 84.4, 77.8, 76.1, 73.6, 73.0 (OCH2),
73.0 (OCH2), 73.0, 72.1 (OCH2), 72.1 (OCH2), 71.6 (OCH2), 71.6
(OCH2), 71.4 (OCH2), 71.4 (OCH2), 71.3, 71.1 (OCH2), 71.1
(OCH2), 62.8 (C-6α/β), 62.7 (C-6α/β), 34.2 (2 × CH2SMe), 15.9 (2
× CH2SMe); HRMS (ESI) m/z [M + Na]+ calcd for C13H26O8SNa
365.1241, found 365.1252.
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[Ru(tpy)(bpy)(13)](PF6)2 ([1](PF6)2). [Ru(tpy)(bpy)Cl]Cl (63 mg,
0.112 mmol) and 13 (93 mg, 0.366 mmol) were dissolved in
deoxygenated H2O (18 mL), and this mixture was heated at 80 °C
for 16 h, after which it was concentrated in vacuo. Puriﬁcation of the
residue by silica column chromatography (100/0/0 to 100/80/20
acetone/water/aq KPF6), followed by puriﬁcation over Sephadex LH-
20 (MeOH), aﬀorded the title compound as a red solid (44 mg, 42.4
μmol, 39%): Rf = 0.69 (100/80/20 acetone/water/aq KPF6);
1H NMR
(400 MHz, CD3OD) δ 9.85 (d, J = 5.7 Hz, 1H, 1), 8.81 (d, J = 8.0 Hz,
1H, 4), 8.77 (d, J = 8.2 Hz, 2H, T3′, T5′), 8.62 (d, J = 8.1 Hz, 2H, T6,
T6″), 8.58 (d, J = 7.8Hz, 1H, 10), 8.44−8.34 (m, 2H, T4′, 3), 8.18−8.04
(m, 3H, T5, T5″, 2), 7.92 (td, J = 7.8, 1.6 Hz, 1H, 9), 7.79 (d, J = 5.6 Hz,
2H, T3, T3″), 7.45 (ddd, J = 7.3, 5.6, 1.4 Hz, 2H, T4, T4″), 7.34−7.26
(m, 1H, 7), 7.23 (ddd, J = 7.3, 5.7, 1.3 Hz, 1H, 8), 4.69 (d, J = 3.7 Hz,
1H, H-1), 3.79−3.68 (m, 2H, CHHH-6, CHHOCH2), 3.64−3.34 (m,
5H, CHHH-6, CHHOCH2, H-2, H-3, H-5), 3.29−3.20 (m, 1H, H-4),
2.12−1.91 (m, 2H, CH2SMe), 1.39 (s, 3H, CH2SMe); 13C NMR (101
MHz, CD3OD) δ 159.3 (Cq arom), 158.7 (Cq arom), 158.1 (Cq arom),
157.9 (Cq arom), 154.3 (CH T3, T3″), 153.5 (CH 1), 150.8 (CH 7), 140.1
(CH T5, T5″), 139.4 (CH T4′), 139.3 (CH 9), 138.3 (CH 3), 129.8 (CH
T4, T4″), 129.4 (CH 2), 128.4 (CH 8), 126.2 (CH T6), 126.2 (CH T6″),
125.9 (CH 4), 125.5 (CH T3′, T5′), 125.1 (CH 10), 100.2 (C-1), 75.1
(C-5), 74.3 (C-3), 73.1 (C-2), 71.7 (C-4), 64.8 (OCH2), 62.8 (C-6),
35.9 (CH2SMe), 14.8 (CH2SMe); HRMS (ESI) m/z [M]
2+ calcd for
C34H37N5O6RuS 372.5749, found 372.5756. Elemental analysis calcd
(%) for [1](PF6)2·2MeOH: C, 39.35; H, 4.13; N, 6.37. Found: 41.45;
H, 4.18; N, 6.35.
[Ru(tpy)(bpy)(15)](PF6)2 ([2](PF6)2). The title compound was
synthesized analogous according to the procedure described for
[1](PF6)2 using [Ru(tpy)(bpy)Cl)]Cl (200 mg, 0.357 mmol) and 15
(100 mg, 0.476 mmol) in H2O (60 mL), aﬀording [2](PF6)2 as an
orange powder (98.4 mg, 99.3 μmol, 28%): Rf = 0.15 (100/80/20
acetone/water/aq KPF6);
1H NMR (400 MHz, CD3OD) δ 10.01 (d, J
= 4.1 Hz, 1H, 1), 8.82 (dt, J = 8.2, 1.1 Hz, 1H, 4), 8.76 (ddd, J = 8.2, 4.3,
0.9 Hz, 2H, T3′, T5′), 8.66−8.56 (m, 3H, T6, T6″, 10), 8.43−8.36 (m,
2H, T4′, 3), 8.13−8.02 (m, 3H, T5, T5″, 2), 7.93 (ddd, J = 8.2, 7.0, 2.1
Hz, 1H, 9), 7.86 (ddd, J = 5.5, 1.5, 0.7 Hz, 1H, T3), 7.80 (ddd, J = 5.5,
1.5, 0.7 Hz, 1H, T3″), 7.44 (ddt, J = 7.8, 5.5, 1.3 Hz, 2H, T4, T4″), 7.27−
7.18 (m, 2H, 7, 8), 3.52 (d, J = 9.1 Hz, 1H, H-1), 3.43 (t, J = 3.6 Hz, 2H,
H-6), 3.02−2.90 (m, 3H, H-2, H-3, H-4), 2.48 (d, J = 8.7 Hz, 1H, H-5),
1.39 (s, 3H, SMe); 13C NMR (101 MHz, CD3OD) δ 163.4 (Cq arom),
160.7 (Cq arom), 160.0 (Cq arom), 159.8 (Cq arom), 158.9 (Cq arom), 158.2
(Cq arom), 158.0 (Cq arom), 154.5 (CH T3), 154.3 (CH T3″), 153.8 (CH
1), 150.4 (CH 7), 140.2 (CHT5), 140.1 (CHT5″), 139.6 (CHT4′), 139.5
(CH 9), 138.2 (CH 3), 129.7 (CH T4), 129.6 (CH T4″), 129.0 (CH 2),
128.5 (CH 8), 126.1 (CH 4), 126.0 (CH T6), 125.9 (CH T6″) 125.3 (CH
T3′, T5′), 125.1 (CH 10), 85.7 (C-1), 82.7 (C-5), 78.6 (C-2), 71.3 (C-
3), 70.0 (C-4), 61.8 (C-6), 9.0 (SMe); HRMS (ESI) m/z [M]2+ calcd
for C32H33N5O5RuS 350.5618, found 350.5629. Elemental analysis
calcd (%) for [2](PF6)2: C, 38.18; H, 3.30; N, 6.96. Found: 38.93; H,
3.39; N, 7.19.
[Ru(tpy)(bpy)(24)](PF6)2 ([3](PF6)2). The title compound was
synthesized analogous according to the procedure described for
[1](PF6)2 using [Ru(tpy)(bpy)Cl)]Cl (101 mg, 0.180 mmol) and 24
(75.7 mg, 0.298 mmol) in H2O (30 mL), aﬀording the title compound
as a hygroscopic orange powder (73.3 mg, 70.7 μmol, 39%): Rf = 0.36
(100/10/20 acetone/water/aq KPF6);
1H NMR (500 MHz, CD3OD)
δ 9.85 (dd, J = 5.6, 0.7 Hz, 1H, 1), 8.81 (dd, J = 17.9, 8.2 Hz, 3H, 4, T3′,
T5′), 8.63 (d, J = 8.1 Hz, 2H, T6, T6″), 8.59 (d, J = 8.2 Hz, 1H, 10),
8.45−8.36 (m, 2H, T4′, 3), 8.14−8.04 (m, 3H, T5, T5″, 2), 7.93 (td, J =
7.8, 1.5 Hz, 1H, 9), 7.80 (td, J = 5.4, 0.8 Hz, 2H, T3, T3″), 7.45 (ddd, J =
7.6, 5.5, 1.3 Hz, 2H, T4, T4″), 7.30 (ddd, J = 5.7, 1.5, 0.7 Hz, 1H, 7), 7.23
(ddd, J = 7.2, 5.7, 1.3 Hz, 1H, 8), 4.15 (d, J = 7.8 Hz, 1H, H-1), 3.88−
3.76 (m, 2H, CHHH-6, CHHOCH2), 3.57 (ddd, J = 12.7, 11.5, 5.6Hz,
2H, CHH H-6, CHH OCH2), 3.26 (m, 1H, H-3), 3.23−3.17 (m, 2H,
H-2, H-4), 3.09 (dd, J = 9.2, 7.8 Hz, 1H, H-5), 1.98 (t, J = 5.6 Hz, 2H,
CH2SMe), 1.39 (s, 3H, CH2SMe);
13C NMR (126 MHz, CD3OD) δ
159.3 (Cq arom), 159.3 (Cq arom), 158.8 (Cq arom), 158.2 (Cq arom), 158.0
(Cq arom), 154.4 (CH T3), 154.4 (CH T3″), 153.6 (CH 1), 150.8 (CH 7),
140.1 (CHT5, T5″), 139.5 (T4′), 139.4 (CH 9), 138.3 (CH 3), 129.8 (CH
T4, T4″), 129.2 (CH 2), 128.4 (CH 8), 126.2 (T6, T6″), 125.9 (CH 4),
125.5 (T3′, T5′), 125.1 (CH 10), 104.2 (C-1), 78.2 (C-3), 78.1 (C-4),
74.9 (C-2), 71.5 (C-5), 66.6 (OCH2), 62.6 (C-6), 35.8 (CH2SMe),
14.8 (CH2SMe); HRMS (ESI) m/z [M]
2+ calcd for C34H37N5O6RuS
372.5749, found 372.5758. Elemental analysis calcd (%) for [3](PF6)2:
C, 39.47; H, 3.60; N, 6.77. Found: 40.57; H, 3.53; N, 7.00.
[Ru(tpy)(bpy)(25)](PF6)2 ([4](PF6)2). The title compound was
synthesized analogous according to the procedure described for
[1](PF6)2 using [Ru(tpy)(bpy)Cl)]Cl (94.2 mg, 0.168 mmol) and
25 (71.0 mg, 0.238 mmol) in H2O (28 mL), aﬀording the title
compound as a hygroscopic orange powder (120 mg, 111 μmol, 66%):
Rf = 0.56 (50/30/20 acetone/water/aq KPF6);
1H NMR (400 MHz,
CD3OD) δ 9.83 (d, J = 5.7 Hz, 1H, 1), 8.79 (dd, J = 14.9, 8.1 Hz, 3H, 4,
T3′, T5′), 8.60 (dd, J = 16.6, 8.1 Hz, 2H, T6, T6″), 8.43−8.34 (m, 2H,
T4′, 3), 8.10 (m, 3H, T5, T5″, 2), 7.91 (td, J = 7.8, 1.5 Hz, 1H, 9), 7.80
(d, J = 4.7Hz, 1H, T3, T3″), 7.51−7.41 (m, 2H, T4, T4″), 7.32−7.27 (m,
1H, 7), 7.23 (ddd, J = 7.2, 5.7, 1.3 Hz, 1H, 8), 4.27 (d, J = 7.8Hz, 1H, H-
1), 3.97−3.89 (m, 1H, CHH OCH2), 3.85 (dd, J = 11.8, 1.7 Hz, 1H,
CHHH-6), 3.71−3.58 (m, 2H, CHHH-6, CHHOCH2), 3.54 (dd, J =
5.4, 3.8Hz, 2H,OCH2), 3.46 (t, J = 5.5Hz, 2H,OCH2), 3.35 (m, J = 2.4
Hz, 1H, H-3), 3.28−3.22 (m, 3H, H-4, H-5), 3.12 (dd, J = 9.0, 7.8 Hz,
1H,), 1.96−1.88 (m, 2H, CH2SMe), 1.40 (s, 3H, CH2SMe); 13C NMR
(101MHz, CD3OD) δ 159.3 (Cq arom), 158.7 (Cq arom), 158.1 (Cq arom),
157.9 (Cq arom), 154.4 (CH T3, T3″), 153.4 (CH 1), 150.8 (CH 7), 140.1
(T5, T5″), 139.5 (CH T4′), 139.3 (CH 9), 138.3 (CH 3), 129.8 (CH T4,
T4″), 129.3 (CH 2), 128.4 (CH 8), 126.2 (CH T6), 125.9 (CH T6″),
125.5 (CH 4), 125.1 (CH T3′, T5′), 104.4 (C-1), 78.1 (C-3), 78.0 (C-4),
75.1 (C-2), 71.6 (C-5), 71.4 (OCH2), 69.7 (OCH2), 68.2 (OCH2),
62.7 (C-6), 35.6 (CH2SMe), 15.2 (CH2SMe); HRMS (ESI)m/z [M]
2+
calcd for C36H41N5O7RuS 394.5880, found 394.5887. Elemental
analysis calcd (%) for [4](PF6)2: C, 40.08; H, 3.83; N, 6.49. Found:
40.78; H, 3.97; N, 6.34.
[Ru(tpy)(bpy)(26)](PF6)2 ([5](PF6)2). The title compound was
synthesized analogous according to the procedure described for
[1](PF6)2 using [Ru(tpy)(bpy)Cl)]Cl (102 mg, 0.182 mmol) and 26
(100 mg, 0.292 mmol) in H2O (30 mL), aﬀording the title compound
as a red solid (130mg, 116 μmol, 65%): Rf = 0.35 (100/80/20 acetone/
water/aq KPF6);
1H NMR (400 MHz, CD3OD) δ 9.83 (d, J = 5.8 Hz,
1H, 1), 8.81 (dd, J = 12.6, 7.9 Hz, 3H, 4, T3′, T5′), 8.62 (dd, J = 17.9, 8.1
Hz, 3H, T6, T6″, 10), 8.46−8.35 (m, 2H, T4′, 3), 8.10 (t, J = 8.3 Hz, 3H,
T5, T5″, 2), 7.93 (t, J = 7.9 Hz, 1H, 9), 7.80 (d, J = 5.8 Hz, 2H, T3, T3″),
7.47 (t, J = 6.6 Hz, 2H, T4, T4″), 7.30 (d, J = 5.8 Hz, 1H, 7), 7.23 (t, J =
6.6 Hz, 1H, 8), 4.26 (d, J = 7.8 Hz, 1H, H-1), 4.06−3.91 (m, 1H, CHH
OCH2), 3.86 (d, J = 11.8 Hz, 1H, CHH H-6), 3.73−3.39 (m, 10H,
CHHH-6, CHHOCH2, 4×OCH2), 3.35 (m, 1H,H-5), 3.26 (d, J = 6.3
Hz, 2H, H-3, H4), 3.10 (t, J = 8.5 Hz, 1H, H-2), 1.90 (d, J = 5.6 Hz, 2H,
OCH2SMe), 1.41 (s, 3H, OCH2SMe);
13C NMR (101 MHz, CD3OD)
δ 157.9 (Cq arom), 157.4 (Cq arom), 156.8 (Cq arom), 156.6 (Cq arom),
153.1 (CH T3, T3″), 152.1 (CH 1), 149.5 (CH 7), 138.8 (CH T5,T5″),
138.2 (CH 9), 138.0 (CH T4′), 136.9 (CH 3), 128.5 (CH T4, T4″), 127.9
(CH 8), 127.1 (CH 2), 124.9 (CH T6, T6″), 124.6 (CH 4), 124.1 (CH T3,
T5′), 123.8 (CH 10), 103.1 (C-1), 76.6 (C-3, C-5), 73.7 (C-2), 70.3 (C-
4), 70.0 (OCH2), 69.9 (OCH2), 69.8 (OCH2), 68.3 (OCH2), 67.0
(OCH2), 61.3 (C-6), 34.1 (OCH2SMe), 14.00 (OCH2SMe); HRMS
(ESI)m/z [M]2+ calcd for C38H45N5O8RuS 416.6011, found 416.6025.
Elemental analysis calcd (%) for [5](PF6)2·3H2O: C, 38.78; H, 4.37; N,
5.95. Found: 39.27; H, 4.68; N, 5.95.
[Ru(tpy)(bpy)(37)]PF6 ([6]PF6). [Ru(tpy)(bpy)(H2O)](PF6)2 (35.9
mg, 45.0 μmol) and H37 (30.3 mg, 44.7 μmol) were dissolved in a
deoxygenatedmixture of acetone/H2O (4:1, 8 mL) and heated at 50 °C
for 16 h, after which the reactionmixture was concentrated in vacuo and
puriﬁed over Sephadex LH-20 (MeOH), aﬀording the title compound
as a red solid (18 mg, 18.4 μmol, 41%): Rf = 0.52 (acetone/water/aq
KPF6 100/80/20);
1HNMR (500MHz, CD3OD) δ 9.84 (d, J = 5.6 Hz,
1H, 1), 8.88−8.80 (m, 3H, 4, T3′, T5′), 8.67 (d, J = 7.1Hz, 2H, T6, T6″),
8.62 (d, J = 7.5 Hz, 1H, 10), 8.43 (q, J = 7.9 Hz, 2H, T4′, 3), 8.17−8.08
(m, 3H, T5, T5″, 2), 7.95 (td, J = 7.8, 1.5 Hz, 1H, 9), 7.81 (d, J = 5.5 Hz,
2H, T3, T3″), 7.48 (ddd, J = 7.2, 5.5, 1.3 Hz, 2H, T4, T4″), 7.36−7.28
(m, 1H, 7), 7.24 (ddd, J = 7.2, 5.7, 1.3 Hz, 1H, 8), 5.23 (d, J = 3.5 Hz,
0.5H, H-1α), 4.45 (d, J = 7.8 Hz, 0.5H, H-1β), 3.99 (dt, J = 11.1, 4.6 Hz,
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0.5H CHHOCH2 α/β), 3.86 (dd, J = 11.8, 2.3 Hz, 0.5H, CHHH-6α),
3.81−3.55 (m, 7.5H, CHHH-6α, CH2 H-6β, H-3α, H-5α, H-5β, CHH
OCH2 α/β, 1 × OCH2 α/β, 2 × OCH2 α+β), 3.51−3.47 (m, 2H,
OCH2), 3.45 (ddd, J = 6.4, 5.2, 1.6 Hz, 2H, OCH2), 3.30−3.20 (m,
1.5H, H-3β, H-4β, H-4α), 3.16 (dd, J = 9.6, 3.5 Hz, 0.5H, H-2α), 2.91
(dd, J = 8.9, 7.8 Hz, 0.5H, H-2β), 1.97−1.89 (m, 2H,CH2SMe), 1.43 (s,
1.5H, CH2SMe α), 1.42 (s, 1.5H, CH2SMe β);
13C NMR (126 MHz,
CD3OD) δ 159.3 (Cq arom), 158.8 (Cq arom), 158.2 (Cq arom), 158.0
(Cq arom), 154.4 (CH T3, T3″), 153.4 (CH 1), 150.8 (CH 7), 140.2 (CH
T5, T5″), 139.6 (CH T5, T5″), 139.4 (CH T4′, 9), 138.4 (CH 3), 129.9
(CH T4, T4″), 129.3 (CH 2), 128.4 (CH 8), 126.3 (CH T6, T6″), 126.0
(CH 4), 125.5 (CH T3′, T5′), 125.2 (CH 10), 98.1 (C-1β), 91.8 (C-1α),
85.2 (C-2β), 82.5 (C-2α), 78.0, 77.6, 73.9, 72.9, 72.6, 71.8, 71.8, 71.6,
71.3, 71.3, 71.2, 70.9, 68.4, 68.3, 62.8 (C-6α/β), 62.7 (C-6α/β), 35.7
(CH2SMe), 35.6 (CH2SMe), 15.4 (CH2SMe), 15.4 (CH2SMe); HRMS
(ESI) m/z [M + H]2+ calcd for C38H45N5O8RuS 416.6011, found
416.6028. Elemental analysis calcd (%) for [6]PF6·3H2O: C, 44.27; H,
4.89; N, 6.79. Found: 44.70; H, 4.73; N, 6.49.
[Ru(tpy)(bpy)(40)]PF6 ([7]PF6).The title compound was synthesized
analogous according to the procedure described for [1](PF6)2 using
[Ru(tpy)(bpy)Cl)]Cl (59.1 mg, 0.105 mmol) and H40 (40.0 mg,
0.117 mmol) in H2O (18 mL), aﬀording the title compound as a red
solid (44.2 mg, 39.3 μmol, 37%): Rf = 0.55 (100/80/20 acetone/water/
aq KPF6);
1H NMR (500 MHz, CD3OD) δ 9.86 (d, J = 5.9 Hz, 1H, 1),
8.96−8.80 (m, 3H, 4, T3′, T5′), 8.74−8.69 (m, 2H, T6, T6″), 8.67−8.62
(m, 1H, 10), 8.51−8.40 (m, 2H, T4′, 3), 8.15 (dtd, J = 9.6, 4.4, 2.4 Hz,
3H, T5, T5″, 2), 8.01−7.93 (m, 1H, 9), 7.87−7.79 (m, 2H, T3, T3″),
7.55−7.46 (m, 2H, T4, T4″), 7.36−7.32 (m, 1H, 7), 7.27 (ddt, J = 7.3,
5.7, 1.5 Hz, 1H, 8), 5.10 (d, J = 3.6 Hz, 0.5H, H-1α), 4.51 (d, J = 7.6 Hz,
0.5H, H-1β), 4.29−3.08 (m, 15H), 1.96 (t, J = 5.4 Hz, 2H, 2 ×
CH2SMe), 1.45 (s, 3H, 2 × CH2SMe); 13C NMR (126 MHz, CD3OD)
δ 159.3 (Cq arom), 158.8 (Cq arom), 158.2 (Cq arom), 158.0 (Cq arom),
154.4 (CH T3, T3″), 153.4 (CH 1), 150.8 (CH 7), 140.2 (CH T5, T5″),
139.6 (CH T4′), 139.4 (CH 9), 138.3 (CH 3), 129.9 (CH T4, T4″), 129.3
(CH 2), 128.4 (CH 8), 126.3 (CH T6, T6″), 126.0 (CH 4), 125.5 (CHT3′,
T5′), 125.2 (CH 10), 98.2 (C-1β), 94.0 (C-1α), 87.6, 84.4, 77.8, 76.1,
73.7, 73.0, 73.0, 72.0, 72.0, 71.6, 71.4, 71.3, 71.2, 71.2, 71.1, 71.1, 68.4,
68.3, 62.6 (C-6α/β), 62.5 (C-6α/β), 35.7 (2 × CH2SMe), 15.4 (2 ×
CH2SMe); HRMS (ESI) m/z [M + H]
2+ calcd for C38H45N5O8RuS
416.6011, found 416.6024. Elemental analysis calcd (%) for [7]PF6·
2H2O: C, 45.02; H, 4.87; N, 6.91. Found: C, 44.82; H, 4.61; N, 6.79.
[Ru(tpy)(bpy)(46)]PF6 ([8]PF6). [Ru(tpy)(bpy)(H2O)](PF6)2 (25.8
mg, 32.0 μmol) and H46 (11.0 mg, 32.1 μmol) were dissolved in a
deoxygenatedmixture of acetone/H2O (4:1, 6 mL) and heated at 50 °C
for 48 h, after which the reactionmixture was concentrated in vacuo and
puriﬁed over Sephadex LH-20 (MeOH), aﬀording the title compound
as a red solid (23 mg, 23.5 μmol, 73%): Rf = 0.61 (100/80/20 acetone/
water/aq KPF6);
1H NMR (500 MHz, CD3OD) δ 9.85 (dd, J = 5.5, 1.1
Hz, 1H, 1), 8.86 (d, J = 8.3 Hz, 1H, 4), 8.83 (d, J = 8.1 Hz, 2H, T3′, T5′),
8.69−8.66 (m, 2H, T6, T6″), 8.63 (dt, J = 8.2, 1.1 Hz, 1H, 10), 8.47−
8.41 (m, 2H, T4′, 3), 8.13 (td, J = 7.8, 1.5 Hz, 3H, T5, T5″, 2), 7.96 (td, J
= 7.9, 1.5 Hz, 1H, 9), 7.82 (dd, J = 5.7, 1.6 Hz, 2H, T3, T3″), 7.49 (ddt, J
= 7.3, 5.4, 1.8 Hz, 2H, T4, T4″), 7.31 (ddd, J = 5.7, 1.6, 0.8 Hz, 1H, 7),
7.25 (ddd, J = 7.2, 5.7, 1.3 Hz, 1H, 8), 5.11 (d, J = 3.7 Hz, 0.5H, H-1α),
4.44 (d, J = 7.8 Hz, 0.5H, H-1β), 3.98−3.05 (m, 15H), 1.95 (t, J = 5.5
Hz, 2H, 2 × CH2SMe), 1.43 (s, 1.5H, CH2SMe), 1.43 (s, 1.5H,
CH2SMe);
13C NMR (126 MHz, CD3OD) δ 159.3 (Cq arom), 158.8
(Cq arom), 158.2 (Cq arom), 158.0 (Cq arom), 154.4 (CH T3), 154.4 (CH
T3′), 153.4 (CH 1), 150.8 (CH 7), 140.2 (CH T5, T5″), 139.6 (CH T4′),
139.4 (CH 9), 138.3 (CH 3), 129.9 (CH T4, T4″), 129.3 (CH 2), 128.4
(CH 8), 126.3 (CH T6, T6″), 125.9 (CH 4), 125.5 (CH T3′, T5′), 125.2
(CH 10), 98.3 (C-1β), 93.9 (C-1α), 80.6, 80.4, 78.1, 77.0, 76.3, 74.9,
73.8, 72.8, 72.0, 71.9, 71.3, 71.2, 71.2, 68.4, 68.4, 62.5 (C-6 α/β), 62.4
(C-6α/β), 35.7 (CH2SMe), 35.6 (CH2SMe), 15.3 (2 × CH2SMe);
HRMS (ESI) m/z [M + H]2+ calcd for C38H45N5O8RuS 416.6011,
found 416.6026. Elemental analysis calcd (%) for [8]PF6·2.5H2O: C,
44.62; H, 4.93; N, 6.85. Found: 45.17; H, 5.16; N, 6.55.
[Ru(tpy)(bpy)(50)]PF6 ([9]PF6).The title compound was synthesized
analogous according to the procedure described for [1](PF6)2 using
[Ru(tpy)(bpy)Cl)]Cl (58.8 mg, 0.105 mmol) and H50 (42.0 mg, 123
μmol) in H2O (18 mL), aﬀording the title compound as a red solid
(23.5 mg, 24.1 μmol, 23%): Rf = 0.36 (16/4/1 acetone/water/1 M
HCl); 1H NMR (500 MHz, CD3OD) δ 9.86 (ddd, J = 5.6, 1.5, 0.7 Hz,
1H, 1), 8.89−8.87 (m, 1H, 4), 8.85 (d, J = 8.2 Hz, 2H, T3′, T5′), 8.69
(dd, J = 8.2, 1.2 Hz, 2H, T6, T6″), 8.67−8.62 (m, 1H, 10), 8.50−8.41
(m, 2H, T4′, 3), 8.16−8.10 (m, 3H, T5, T5″, 2), 7.97 (td, J = 7.8, 1.5 Hz,
1H, 9), 7.84 (ddd, J = 5.6, 1.5, 0.7 Hz, 2H, T3, T3″), 7.50 (ddd, J = 7.2,
5.6, 1.4 Hz, 2H, T4, T4″), 7.33 (dq, J = 5.9, 0.9 Hz, 1H, 7), 7.26 (ddd, J =
7.2, 5.7, 1.3 Hz, 1H, 8), 5.10 (d, J = 3.6 Hz, 0.5H, H-1α), 4.50 (d, J = 7.6
Hz, 0.5H, H-1β), 3.99−3.08 (m, 15H), 1.96 (t, J = 5.5 Hz, 2H, 2 ×
CH2SMe), 1.44 (s, 3H, 2 × CH2SMe);
13C NMR (126 MHz, CD3OD)
δ 159.3 (Cq arom), 158.8 (Cq arom), 158.2 (Cq arom), 158.0 (Cq arom),
154.4 (CH T3′), 153.4 (CH 1), 150.8 (CH 7), 140.2 (CH T5, T5″), 139.6
(CH T4′), 139.4 (CH 9), 138.3 (CH 3), 129.9 (CH T4, T4″), 129.3 (CH
2), 128.4 (CH 8), 126.3 (CH T6, T6″), 126.0 (CH 4), 125.6 (CH T3′),
125.5 (CH T5′), 125.1 (CH 10), 98.2 (C-1β), 94.0 (C-1α), 87.6, 84.4,
77.8, 76.1, 73.7, 73.0, 73.0, 73.0, 72.0, 72.0, 71.3, 71.3, 71.2, 71.2, 71.1,
68.4, 68.3, 62.6 (C-6α/β), 62.5 (C-6α/β), 35.7 (2× CH2SMe), 15.4 (2
× CH2SMe); HRMS (ESI) m/z [M + H]
2+ calcd for C38H45N5O8RuS
416.6011, found 416.6026. Elemental analysis calcd (%) for [9]PF6·
2H2O: C, 45.02; H, 4.87; N, 6.91. Found: C, 44.88; H, 4.59; N, 6.78.
[Ru(S-tpy)(bpy)(26)]PF6 ([10]PF6). A deoxygenated solution of 31
(40.0 mg, 0.0661 mmol) and 26 (48.0 mg, 0.140 mmol) in H2O (11
mL) was heated at 80 °C for 16 h, after which it was concentrated in
vacuo. The resulting residue was then puriﬁed over silica (100/0/0 to
100/95/5 in acetone/water/aq KPF6), followed by puriﬁcation over
Sephadex LH-20 (MeOH) to aﬀord the title compound as a red
microcrystalline solid (18 mg, 24.4 μmol, 37%): Rf = 0.46 (100/80/20
acetone/water/aq KPF6);
1H NMR (500 MHz, CD3OD) δ = 9.84 (d, J
= 5.9 Hz, 1H, 1), 9.03 (s, 2H, T3′, T5′), 8.81 (d, J = 8.2 Hz, 1H, 4), 8.73
(d, J = 8.1 Hz, 2H, T6, T6″), 8.58 (d, J = 8.2 Hz, 1H, 10), 8.43 (t, J = 7.9
Hz, 1H, 3), 8.13 (dt, J = 13.2, 7.4 Hz, 3H, 2, T4, T4″), 7.95 (t, J = 7.7 Hz,
1H, 9), 7.81 (d, J = 5.9 Hz, 2H, T3, T3″), 7.60−7.43 (m, 2H, T5, T5″),
7.25 (dt, J = 12.7, 6.0 Hz, 2H, 8, 7), 4.30 (d, J = 7.8 Hz, 1H, H-1), 4.00
(dd, J = 10.6, 5.3 Hz, 1H, CHHOCH2), 3.86 (d, J = 12.0 Hz, 1H, CHH
H-6), 3.67 (m, 4H, CHH H-6, CHHOCH2, 2 ×OCH2), 3.57 (dd, J =
5.7, 3.4 Hz, 2H, OCH2), 3.48 (dd, J = 5.8, 3.4 Hz, 2H, OCH2), 3.44 (t, J
= 5.5 Hz, 2H, OCH2), 3.41−3.36 (m, 1H, H-3), 3.29 (m, 2H, H-4, H-
5), 3.14 (t, J = 8.5 Hz, 1H, H-2), 1.91 (t, J = 5.5 Hz, 2H, CH2SMe), 1.41
(s, 3H, CH2SMe);
13C NMR (126 MHz, CD3OD) δ 159.2 (Cq arom),
158.7 (Cq arom), 157.9 (Cq arom), 157.7 (Cq arom), 154.8 (Cq arom), 154.2
(CH T3, T3″), 153.2 (CH 1), 150.6 (CH 7), 140.4 (CH T4, T4″), 139.8
(CH 3), 139.6 (CH 9), 130.2 (CH T5, T5″), 129.3 (CH 8) 128.5 (CH 2),
126.7 (CH T6, T6″), 125.9 (CH 4), 125.1 (CH 10), 121.7 (CH T3′, T5′),
104.2 (C-1), 77.8 (C-3, C-5), 74.9 (C-2), 71.4 (C-5), 71.1 (OCH2),
71.0 (OCH2), 69.7 (OCH2), 68.0 (OCH2), 62.5 (C-6), 35.2
(CH2SMe), 15.2 (CH2SMe); HRMS (ESI) m/z [M]
+ calcd for
C38H44N5O11RuS2 912.1517, found 912.1543. Elemental analysis calcd
(%) for [10]PF6·0.5KPF6·5H2O: C, 36.84; H, 4.39; N, 5.65. Found:
36.83; H, 4.40; N, 5.36.
Δ/Λ-[Ru(tpy)(bpy)(28)](PF6)2 ([11]Cl2). [Ru(bpy2)Cl2] (73.0 mg,
0.151 mmol) and 28 (46.0 mg, 0.146 mmol) were dissolved in
deoxygenated H2O (10 mL), and this mixture was heated at 80 °C for
16 h, after which the mixture was concentrated in vacuo. Puriﬁcation by
Sephadex LH-20 (MeOH) aﬀorded the title compound as an
inseparable mixture of diastereomers (69.0 mg, 0.0864 mmol, 59%):
Rf = 0.28 (16/4/1 acetone/water/1 M HCl);
1H NMR (500 MHz,
CD3OD) δ 10.02 (dd, J = 5.7, 1.4 Hz, 1H), 9.86 (dd, J = 5.7, 1.4 Hz,
1H), 9.50 (dd, J = 5.7, 1.4 Hz, 1H), 9.42 (dd, J = 5.7, 1.3 Hz, 1H), 8.81
(d, J = 8.2 Hz, 2H), 8.79−8.76 (m, 2H), 8.69−8.62 (m, 4H), 8.45−8.36
(m, 4H), 8.12 (tt, J = 8.0, 1.8 Hz, 4H), 8.06 (dddd, J = 13.5, 7.3, 5.6, 1.4
Hz, 5H), 7.63 (td, J = 5.7, 1.4 Hz, 2H), 7.57 (ddd, J = 7.5, 5.7, 1.4 Hz,
2H), 7.49−7.42 (m, 4H), 4.65 (d, J = 7.8 Hz, 1H), 4.58 (d, J = 7.8 Hz,
1H), 3.92 (ddd, J = 19.8, 11.8, 1.9 Hz, 2H), 3.78−3.70 (m, 1H), 3.62
(dd, J = 11.9, 6.4Hz, 1H), 3.50−3.35 (m, 10H), 3.30 (t, J = 8.2Hz, 1H),
3.27−3.20 (m, 2H), 3.13 (dd, J = 14.0, 6.4 Hz, 1H), 3.02 (dd, J = 13.9,
7.1 Hz, 1H), 2.92 (dd, J = 13.1, 2.1 Hz, 1H), 2.80 (dd, J = 13.1, 1.7 Hz,
1H), 1.53 (s, 3H), 1.50 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H); 13C NMR
(126 MHz, CD3OD) δ 159.1, 159.1, 159.0, 158.9, 158.1, 158.0, 157.9,
155.4, 155.0, 154.9, 154.8, 152.0, 152.0, 151.9, 151.9, 140.3, 140.2,
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130.8, 130.0, 129.9, 129.5, 129.3, 129.0, 129.0, 128.9, 126.2, 126.1,
126.0, 125.6, 125.6, 125.5, 125.4, 104.2, 103.6, 78.4, 78.3, 78.3, 78.2,
75.3, 75.3, 75.2, 71.6, 71.6, 62.7, 40.5, 38.6, 38.4, 37.4, 18.5, 18. 1, 16.1,
16.0; HRMS (ESI) m/z [M]2+ calcd for C31H38N4O6RuS2 364.0633,
found 364.0646. Elemental analysis calcd (%) for [11]Cl2·3H2O: C,
43.66; H, 5.20; N, 6.57. Found: 43.34; H, 5.35; N, 6.29.
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